WO2020120694A1 - Pesticidally-active bicyclic heteroaromatic compounds - Google Patents

Pesticidally-active bicyclic heteroaromatic compounds Download PDF

Info

Publication number
WO2020120694A1
WO2020120694A1 PCT/EP2019/084936 EP2019084936W WO2020120694A1 WO 2020120694 A1 WO2020120694 A1 WO 2020120694A1 EP 2019084936 W EP2019084936 W EP 2019084936W WO 2020120694 A1 WO2020120694 A1 WO 2020120694A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
spp
methyl
ccn
optionally substituted
Prior art date
Application number
PCT/EP2019/084936
Other languages
French (fr)
Inventor
Aurelien BIGOT
Jürgen Harry SCHAETZER
Pierre Joseph Marcel Jung
André Stoller
Julien Daniel Henri GAGNEPAIN
Roger Graham Hall
Stefano RENDINE
Nicola COMPAGNONE
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Publication of WO2020120694A1 publication Critical patent/WO2020120694A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

Definitions

  • the present invention relates to pesticidally active, in particular insecticidally active fused bicyclic heterocyclic compounds, to compositions comprising those compounds, and to their use for controlling animal pests (including arthropods and in particular insects or representatives of the order Lepidoptera and Hemiptera).
  • Insecticidally-active fused bicyclic heteroaromatic compounds are known, for example, from WO 2013/149903, WO 2007/1 15647, WO 2012/136751 , WO 2013/144088, WO 2013/1501 15, WO 2012/152741 and WO 2014/076272.
  • W is O or S
  • R 1 is Ci-C6alkyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or Ci-C6haloalkyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2;
  • C2-C6alkenyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or C2-C6haloalkenyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2;
  • R 2 is independently selected from halogen, cyano, amino, hydroxyl, Ci-C 4 alkyl, Ci-C 4 haloalkyl, Ci-C 4 haloalkoxy, Ci-C 4 alkoxy, C 2 -C 4 alkenyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkynyl, C 2 -C 4 haloalkynyl, C1-C4 alkylsulfanyl, Ci-C 4 alkylsulfinyl, Ci-C 4 alkylsulfonyl, Ci-C 4 haloalkylsulfanyl, Ci-C 4 haloalkylsulfinyl, Ci- C 4 haloalkylsulfonyl and cyclopropyl;
  • a compound according to Formula (I) as an insecticide, acaricide, nematicide or molluscicide.
  • the use may exclude methods forthe treatment ofthe human or animal body by surgery or therapy.
  • amino means an -NH2 group.
  • Ci-C6alkylsulfanyl refers to a radical of the formula RxS- wherein R x is a Ci-C6alkyl radical as generally defined above.
  • Ci-C6haloalkylaminocarbonyl refers to a Ci-C6alkylaminocarbonyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
  • U2 is phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl or pyrazinyl, each optionally substituted by (i) 1 , 2 or 3 independently selected halogen groups, or (ii) a single L4 group selected from cyano and Ci-C 4 haloalkoxy.
  • U3 is selected from halogen, Ci-C 4 alkyl or Ci-C 4 haloalkyl. More preferably, U3 is selected from fluoro, chloro, bromo, methyl, ethyl, trifluoromethyl.
  • U4 is nitro, cyano, amino, hydroxyl, -SCN, -CO2H, Ci-C 4 alkyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C3-C6cycloalkyl-Ci-C 4 alkyl, C3-C6halocycloalkyl-Ci-C 4 alkyl, Ci-C 4 haloalkyl, Ci-C 4 alkoxy, Ci-C 4 alkoxy- Ci-C 4 alkyl, Ci-C 4 alkoxy-Ci-C 4 alkoxy, cyano-Ci-C 4 alkyl, cyano-Ci-C 4 haloalkyl, C 2 -C 4 alkenyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkynyl, C 2 -C 4 haloalkynyl, Ci-C 4 haloalkoxy, Ci-C 4 haloalk
  • n 0, 1 or 2. In some embodiments of the invention, m is 0. In some embodiments of the invention, m is 1 . In some embodiments of the invention, m is 2. Preferably, m is 0 or 1 , and more preferably, m is 0.
  • R 2 is independently selected from halogen, cyano, amino, hydroxyl, Ci-C 4 alkyl, Ci-C 4 haloalkyl, Ci- C 4 haloalkoxy, Ci-C 4 alkoxy, C 2 -C 4 alkenyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkynyl, C 2 -C 4 haloalkynyl, C1-C4 alkylsulfanyl, Ci-C 4 alkylsulfinyl, Ci-C 4 alkylsulfonyl, Ci-C 4 haloalkylsulfanyl, Ci-C 4 haloalkylsulfinyl, Ci- C 4 haloalkylsulfonyl and cyclopropyl.
  • R 3a and R 3b are independently selected from hydrogen, halogen, Ci-C 4 alkyl, Ci-C 4 haloalkyl, Ci- C 4 alkoxy, Ci-C 4 haloalkoxy and cyano.
  • R 3a is hydrogen and R 3b is selected from hydrogen, chloro, fluoro, methyl, ethyl, trifluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, methoxy or ethoxy. More preferably, R 3a is hydrogen and R 3b is hydrogen or methyl. Most preferably, R 3a is hydrogen and R 3b is hydrogen.
  • R 4 is selected from one of Y1 to Y4;
  • R4 is selected from one of Y2 or Y3. In one embodiment of the invention, R4 is Y2. In another embodiment of the invention, R4 is Y3.
  • R 1 is defined in accordance with the present invention, and X represents hydrogen or R 2 as methyl.
  • the compound of Formula (I) is:
  • R 1 is defined in accordance with the present invention, and X represents hydrogen or R 2 as methyl.
  • the compound according to Formula (I) is selected from a compound 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below).
  • compounds of formula (II) wherein R 2 , R 3a , R 3b , R 4 and m are as defined for formula (I), may be prepared by the reaction of a compound of formula (III) and a compound of formula (IV), wherein LG is a leaving group such as, for example, halide, in the presence, or not, of a suitable base, such as for example sodium carbonate, potassium carbonate or cesium carbonate, or lithium alkoxide, sodium alkoxide or potassium alkoxide, in suitable solvents that may include, for example, acetonitrile, DMF, 1 ,4-dioxane, and usually upon heating of the reaction mixture at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture, optionally under microwave heating conditions.
  • a catalyst may be used in this reaction, including sodium iodide or tert-butylammonium iodide.
  • compounds of formula (III) could be prepared as described in Scheme 2.
  • compounds of formula (III) wherein R 2 and m are defined as forformula (I) may be prepared by a Curtius rearrangement from compounds of formula (X) which are commercially available, wherein R 2 and m are as described for formula (I), by treatment with diphenylphosphoryl azide (DPPA), in the presence of a suitable base, such as for example trimethylamine, in suitable solvents that may include, for example, ethanol, tert-butanol, 1 ,4-dioxane, tetrahydrofuran, usually upon heating at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture.
  • DPPA diphenylphosphoryl azide
  • suitable solvents that may include, for example, ethanol, tert-butanol, 1 ,4-dioxane, tetrahydrofuran, usually upon heating at temperatures between room temperature and 200°
  • compounds of formula (II) wherein R 2 , R 3a , R 3b , R 4 and m are defined as forformula (I) can be prepared by the reaction of compounds of formula (V) and compounds of formula (VI), wherein LGi and LG2 are independently leaving groups, such as, for example, halide, an aryloxy group or imidazolyl group.
  • the reaction can be performed at 0°C to the boiling point of the solvent and preferably in the presence, or not, of a base, which may be, for example, ammonia, pyridine, Hiinig’s base, triethylamine or sodium carbonate and in a solvent such as, for example, dichloromethane or a mixture of solvents, such as methanol and dichloromethane
  • a base which may be, for example, ammonia, pyridine, Hiinig’s base, triethylamine or sodium carbonate
  • a solvent such as, for example, dichloromethane or a mixture of solvents, such as methanol and dichloromethane
  • Compounds of formula (V) wherein R 2 , R 3a , R 3b , R 4 and m are defined as for formula (I) may be prepared by the hydrolysis of compounds of formula (IX) by treatment with a suitable strong acid, such as, for example a 37% concentrated aqueous solution of HCI, usually upon heating at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture, and optionally under microwave heating conditions.
  • a suitable strong acid such as, for example a 37% concentrated aqueous solution of HCI
  • compounds of formula (V) wherein R 2 , R 3a , R 3b R 4 and m are defined as forformula (I) may be prepared by the hydrolysis of compounds of formula (VIII), by treatment with a suitable strong acid, like, for example a 37% concentrated aqueous solution of hydrogen bromide, usually upon heating at temperatures between room temperature and 200°C, preferably between 20°C to the boiling point of the reaction mixture, and optionally under microwave heating conditions.
  • a suitable strong acid like, for example a 37% concentrated aqueous solution of hydrogen bromide
  • Compounds of formula (IX) wherein R 2 , R 3a , R 3b R 4 and m are defined as for formula (I), may be prepared by hydrolysis of compounds of formula (VIII) by treatment with a suitable acid, such as, for example trifluoroacetic acid (TFA), in suitable solvents that may include, for example, dichloromethane or 1 ,2-dichloroethane, and usually upon heating at temperatures between room temperature and 200°C, preferably between 20°C to the boiling point of the reaction mixture, optionally under microwave heating conditions.
  • a suitable acid such as, for example trifluoroacetic acid (TFA)
  • suitable solvents may include, for example, dichloromethane or 1 ,2-dichloroethane, and usually upon heating at temperatures between room temperature and 200°C, preferably between 20°C to the boiling point of the reaction mixture, optionally under microwave heating conditions.
  • Compounds of formula (VIII) wherein R 2 , R 3a , R 3b R 4 and m are as defined for formula (I), may be prepared by reaction between compounds of formula (VII) and compounds of formula (IV), wherein LG is a leaving group such as, for example, halide, in the presence, or not, of a suitable base, such as for example sodium carbonate, potassium carbonate or cesium carbonate, or lithium ethanoate, sodium ethanoate or potassium ethanoate, in suitable solvents that may include, for example, acetonitrile, DMF, 1 ,4-dioxane, and usually upon heating at temperatures between room temperature and 200°C, preferably between 20°C to the boiling point of the reaction mixture, and optionally under microwave heating conditions.
  • a suitable base such as for example sodium carbonate, potassium carbonate or cesium carbonate, or lithium ethanoate, sodium ethanoate or potassium ethanoate
  • suitable solvents may include, for example, acet
  • compounds of formula (VII) wherein R 2 and m are defined as for formula (I) may be prepared from compounds of formula (XII) by treatment with, for example, di-tert-butyl dicarbonate ((BOC)20), in a suitable solvent that may include, for example, dichloromethane, 1 ,2-dichloroethane, tetrahydrofuran or by performing the reaction in molten di-tert-butyl dicarbonate, usually upon heating at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture.
  • An alternative protecting group could be used such as, eg, benzyl.
  • Compounds of formula (XII) may be prepared by the reaction of compounds of formula (XI) and compounds of formula (XIII), wherein LGi and LG2 are independently from each other leaving groups, like, for example amino, halide or imidazole.
  • the reaction can be performed at 0°C to the boiling point of the solvent and preferably in the presence of a base, which could be, for example, pyridine, Hiinig’s base, triethylamine or sodium carbonate.
  • a base which could be, for example, pyridine, Hiinig’s base, triethylamine or sodium carbonate.
  • Compounds of formula (XV) wherein R 2 , R 1 and m are defined as for formula (I) can be prepared by the reaction of compounds of formula (XIV) and compounds of formula (VI), wherein LGi and LG2 are independently from each other leaving groups, such as, for example, halide such as chloride, an aryloxy group or imidazolyl.
  • the reaction can be performed at 0°C to the boiling point of the solvent and preferably in the presence of a base, which may be, for example, pyridine, Hiinig’s base, triethylamine or sodium carbonate.
  • compounds of formula (XV) wherein R 2 , R 3a , R 3b , R 4 and m are defined as for formula (I) can be prepared by the reaction of compounds of formula (XIV) and compounds of formula (VI), wherein LGi and LG2 are identical such as, for example urea.
  • the reaction can be performed at 50°C to 200°C or to the boiling point of the reaction mixture. In presence or not of a solvent such as dimethyl formamide or tetrahydrofuran.
  • Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N- diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1 ,8-diazabicyclo[5.4.0]undec-7-ene (DBU).
  • DBU ,8-diazabicyclo[5.4.0]undec-7-ene
  • Reactions are advantageously carried out in a temperature range from approximately -80 °C to approximately 140 °C, preferably from approximately -30 °C to approximately 100 °C, in many cases in the range between ambient temperature and approximately 80 °C.
  • a compound of formula (I) can be converted in a manner known per se into another compound of formula (I) by replacing one or more substituents of the starting compound of formula (I) in the customary manner by (an)other substituent(s) according to the invention.
  • Salts of compounds of formula (I) can be prepared in a manner known per se.
  • acid addition salts of compounds of formula (I) are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.
  • Salts of compounds of formula (I) can be converted in the customary manner into the free compounds (I), acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.
  • Salts of compounds of formula (I) can be converted in a manner known per se into other salts of compounds of formula (I), acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
  • a salt of inorganic acid such as hydrochloride
  • a suitable metal salt such as a sodium, barium or silver salt
  • the compounds of formula (I), which have salt-forming properties can be obtained in free form or in the form of salts.
  • the compounds of formula (I) and, where appropriate, the tautomer’s thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule, the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and herein below, even when stereochemical details are not mentioned specifically in each case.
  • Diastereomeric mixtures or racemic mixtures of compounds of formula (I), in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diastereomers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.
  • Enantiomeric mixtures such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl cellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the di
  • Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.
  • the biologically more effective isomer for example enantiomer or diastereomer, or isomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity.
  • the compounds of formula (I) and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.
  • the compounds of formula (I) according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and may be well-tolerated by warm-blooded species, fish and plants.
  • the compounds of formula (I) may have a beneficial safety profile towards non-target species, such as bees, and accordingly a good toxicity profile.
  • the active ingredients according to the invention may act against all or individual developmental stages of normally sensitive, but also resistant pests, such as insects or representatives of the order Acarina.
  • the insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate.
  • Haematopinus spp. Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp., from the order Coleoptera, for example,
  • Agriotes spp. Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp., Astylus atromaculatus, Ataenius spp., Atomaria linearis, Chaetocnema tibialis, Cerotoma spp., Conoderus spp., Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp., Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa decemLineata, Lissorhoptrus spp., Liogenys spp., Maecolaspis spp., Maladera
  • Thysanoptera for example
  • the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species, cyst-forming nematodes, Globodera rostochiensis and other Globodera species, Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species, Seed gall nematodes, Anguina species, Stem and foliar nematodes, Aphelenchoides species, Sting nematodes, Belonolai
  • H. aperta Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus), Lymnaea, Milax (M. gagates, M. marginatus, M. sowerbyi), Opeas, Pomacea (P. canaticulata), Vallonia and Zanitoides.
  • Compounds according to Formula (I) may find utility in controlling resistant populations of insects previously sensitive to the neonicotinoid class of pesticidal (insecticidal) agents (the “neonicotinoids”). Accordingly, the present invention may relate to a method of controlling insects which are resistant to a neonicotinoid insecticide comprising applying a compound of Formula (I) (eg, a single compound selected from compounds 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below)) to a neonicotinoid-resistant insect.
  • a compound of Formula (I) eg, a single compound selected from compounds 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below)
  • the present invention may relate to the use of a compound of Formula (I) (eg, a single compound selected from compounds 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below) as an insecticide against neonicotinoid-resistant insects.
  • a compound of Formula (I) eg, a single compound selected from compounds 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below) as an insecticide against neonicotinoid-resistant insects.
  • Such neonicotinoid-resistant insects may include insects from the order Lepidoptera or Hemiptera, in particular from the family Aphididae.
  • Resistance may be defined as“a heritable change in the sensitivity of a pest population that is reflected in the repeated failure of a product containing an insecticidal active ingredient to achieve the expected level of control when used according to the label recommendation for that pest species” (IRAC).
  • Cross- resistance occurs when resistance to one insecticide confers resistance to another insecticide via the same biochemical mechanism. This can happen within insecticide chemical groups or between insecticide chemical groups. Cross- resistance may occur even if the resistant insect has never been exposed to one of the chemical classes of insecticide.
  • Xenorhabdus spp. such as Photorhabdus luminescens, Xenorhabdus nematophilus, toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins, toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins, agglutinins, proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors, ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin, steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP- glycosyl-transferase, cholesterol oxidases, ecd
  • 5-endotoxins for example CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A
  • Vip vegetative insecticidal proteins
  • Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ).
  • Truncated toxins for example a truncated CrylAb, are known.
  • Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.
  • Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651 .
  • the toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects.
  • insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera).
  • transgenic crops are:
  • MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
  • MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
  • NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810.
  • NK603 c MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225).
  • PRPs pathogenesis-related proteins
  • Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818 and EP-A-0 353 191 .
  • the methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • Crops may also be modified for enhanced resistance to fungal (for example Fusarium, Anthracnose, or Phytophthora), bacterial (for example Pseudomonas) or viral (for example potato leafroll virus, tomato spotted wilt virus, cucumber mosaic virus) pathogens.
  • fungal for example Fusarium, Anthracnose, or Phytophthora
  • bacterial for example Pseudomonas
  • viral for example potato leafroll virus, tomato spotted wilt virus, cucumber mosaic virus
  • Crops that are tolerance to abiotic stress include those that have enhanced tolerance to drought, high salt, high temperature, chill, frost, or light radiation, for example through expression of NF-YB or other proteins known in the art.
  • Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1 , KP4 or KP6 toxins, stilbene synthases, bibenzyl synthases, chitinases, glucanases, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225), antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called "plant disease resistance genes", as described in WO 03/000906).
  • ion channel blockers such as blockers for sodium and calcium channels
  • the viral KP1 , KP4 or KP6 toxins stilbene synthases, bibenzyl synthases, chitinases, glucanases, the so-called
  • compositions according to the invention are the protection of stored goods and store ambients and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type.
  • compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.
  • a substrate selected from nonwoven and fabric material comprising a composition which contains a compound of formula I.
  • compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees.
  • the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following Table:
  • the present invention may be also used to control any insect pests that may be present in turfgrass, including for example beetles, caterpillars, fire ants, ground pearls, millipedes, sow bugs, mites, mole crickets, scales, mealybugs ticks, spittlebugs, southern chinch bugs and white grubs.
  • the present invention may be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs and adults.
  • the present invention may be used to control insect pests that feed on the roots of turfgrass including white grubs (such as Cyclocephala spp. (e.g. masked chafer, C. lurida), Rhizotrogus spp. (e.g. European chafer, R. majalis), Cotinus spp. (e.g. Green June beetle, C. nitida), Popillia spp. (e.g. Japanese beetle, P. japonica), Phyllophaga spp. (e.g. May/June beetle), Ataenius spp. (e.g. Black turfgrass ataenius, A.
  • white grubs such as Cyclocephala spp. (e.g. masked chafer, C. lurida), Rhizotrogus spp. (e.g. European chafer, R. majalis), Cotinus spp
  • the present invention may also be used to control insect pests ofturfgrass that live above the ground and feed on the turfgrass leaves, including chinch bugs (such as southern chinch bugs, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), rhodesgrass mealybug (Antonina graminis), two-lined spittlebug ( Propsapia bicincta), leafhoppers, cutworms ( Noctuidae family), and greenbugs.
  • chinch bugs such as southern chinch bugs, Blissus insularis
  • Bermudagrass mite Eriophyes cynodoniensis
  • rhodesgrass mealybug Antonina graminis
  • two-lined spittlebug Propsapia bicincta
  • leafhoppers Tricotuidae family
  • cutworms Noctuidae family
  • the active ingredients can also be contained in very fine microcapsules.
  • Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release).
  • Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95 % by weight of the capsule weight.
  • the active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution.
  • the rates of application vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop.
  • a general guideline compounds may be applied at a rate of from 1 to 2000 l/ha, especially from 10 to 1000 l/ha.
  • an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,
  • TX Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator, and other biologicals including: abscisic acid + TX, bioSea® + TX, Chondrostereum purpureum (Chontrol Paste®) + TX, Colletotrichum gloeosporio

Abstract

A compound of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.

Description

PESTICIDALLY-ACTIVE BICYCLIC HETEROAROMATIC COMPOUNDS
The present invention relates to pesticidally active, in particular insecticidally active fused bicyclic heterocyclic compounds, to compositions comprising those compounds, and to their use for controlling animal pests (including arthropods and in particular insects or representatives of the order Lepidoptera and Hemiptera).
Insecticidally-active fused bicyclic heteroaromatic compounds are known, for example, from WO 2013/149903, WO 2007/1 15647, WO 2012/136751 , WO 2013/144088, WO 2013/1501 15, WO 2012/152741 and WO 2014/076272.
It has now been found that further fused bicyclic heteroaromatic compounds have insecticidal properties.
According to the present invention, there is provided a compound of Formula (I):
Figure imgf000002_0001
wherein:
W is O or S;
R1 is Ci-C6alkyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or Ci-C6haloalkyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2;
or
C2-C6alkenyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or C2-C6haloalkenyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2;
or
C2-C6alkynyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or C2-C6haloalkynyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2;
or
C3-C6cycloalkyl optionally substituted by 1 or 2 substituents independently selected from U3 or a single substituent selected from U2;
or
cyano, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl or phenylcarbonyl; Ui is nitro, cyano, amino, hydroxyl, CO2H, C3-C6cycloalkyl, C3-C6halocycloalkyl, Ci-C4alkoxy, Ci-C4haloalkoxy, Ci-C2alkoxy-Ci-C2alkoxy, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci- C4alkoxycarbonyl, Ci-C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl, C3-C4cycloalkylcarbonyl, =N- 0(Ci-C4alkyl), =N-0(Ci-C4haloaikyl), -Si(Ci-C4alkyl)3, (Ci-C4haloalkyl)NH-, (Ci-C4haloalkyl)2N-, (C1-C4 haloalkyl)(Ci-C4alkyl)N-, (Ci-C4alkyl)NH-, (Ci-C4alkyl)2N-, (C3-C6cycloalkyl)NH-, (C3-C6cycloalkyl)(Ci- C4alkyl)N-, Ci-C4alkylcarbonylamino, Ci-C4haloalkylcarbonylamino, aminocarbonyl, N-Ci- C4alkylaminocarbonyl, (N,N-di-Ci-C4alkylamino)carbonyl, C3-C6cycloalkylaminocarbonyl, Ci- C4haloalkylaminocarbonyl, C3-C6halocycloalkylaminocarbonyl or phenylaminocarbonyl, wherein the phenyl group is optionally substitued by a single substituent selected from halogen, methyl, methoxy or trifluoromethyl;
U2 is phenyl, heteroaryl wherein the heteroaryl moiety is a 5- or 6-membered monocyclic aromatic ring which comprises 1 , 2, 3, or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur, or a 5- or 6-membered saturated or partially saturated heterocyclic ring wherein the heterocyclic ring comprises 1 to 3 heteroatoms selected from nitrogen, oxygen and sulfur, and wherein each phenyl, heteroaryl or heterocyclic ring is optionally substituted by: (i) 1 , 2, 3, 4 or 5 independently selected halogen groups, or (ii) 1 or 2 groups independently selected from L4 and optionally a halogen group;
L is halogen, nitro, cyano, amino, hydroxyl, -CO2H, Ci-C4alkyl, Ci-C4haloalkyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C3-C6halocycloalkyl-Ci-C4alkyl, C3-C6cycloalkyl-Ci-C4alkyl, Ci-C4alkoxy, Ci- C4alkoxy-Ci-C4alkyl, Ci-C4haloalkoxy, Ci-C4haloalkoxy-Ci-C4alkyl, cyano-Ci-C4alkyl, cyano-Ci- C4haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C2-C6haloalkynyl, Ci-C4alkylsulfanyl, Ci- C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci-C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl and - C(0)NH2;
U4 is nitro, cyano, amino, hydroxyl, -SCN, -CO2H, Ci-C4alkyl, C3-C6cycloalkyl, C3- Cehalocycloalkyl, C3-C6cycloalkyl-Ci-C4alkyl, C3-C6halocycloalkyl-Ci-C4alkyl, Ci-C4haloalkyl, Ci- C4alkoxy, Ci-C4alkoxy-Ci-C4alkyl, Ci-C4alkoxy-Ci-C4alkoxy, cyano-Ci-C4alkyl, cyano-Ci-C4haloalkyl, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, Ci-C4haloalkoxy, Ci-C4haloalkoxy-Ci- C4alkyl, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci- C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci- C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl, (Ci-C4alkyl)NH-, (Ci-C4alkyl)2N-, (C3-C6cycloalkyl)NH-, (C3-C6cycloalkyl)2N-, Ci-C4alkylcarbonylamino, C3-C6cycloalkylcarbonylamino, Ci-
C4haloalkylcarbonylamino, C3-C6halocycloalkylcarbonylamino, Ci-C4alkylaminocarbonyl, C3-C6 cycloalkylaminocarbonyl, Ci-C4haloalkylaminocarbonyl, C3-C6halocycloalkylaminocarbonyl, C3-C6 cycloalkylcarbonyl, C3-C6 halocycloalkylcarbonyl, -SFs or -C(0)NH2; m is 0, 1 or 2;
R2 is independently selected from halogen, cyano, amino, hydroxyl, Ci-C4alkyl, Ci-C4haloalkyl, Ci-C4haloalkoxy, Ci-C4alkoxy, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, C1-C4 alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl and cyclopropyl;
R3a and R3b are independently selected from hydrogen, halogen, Ci-C4alkyl, Ci-C4haloalkyl, Ci- C4alkoxy and cyano;
R4 is selected from one of Y1 to Y4:
Figure imgf000004_0001
wherein n is 0, 1 or 2; and
U is independently selected from halogen, cyano, nitro, hydroxyl, amino, Ci-C4alkyl, Ci- C4haloalkyl, Ci-C4alkoxy, Ci-C4haloalkoxy, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, Ci-C4haloalkoxy-Ci-C4alkyl, Ci-C4alkoxy-Ci-C4alkyl, Ci-C4alkylsulfanyl, Ci- C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, formyl, cyclopropyl, Ci-C4alkylcarbonyl or C3-C6cycloalkylcarbonyl; or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
Surprisingly, it has been found that the novel compounds of Formula (I) have, for practical purposes, a very advantageous level of biological activity for protecting plants against insects.
According to a second aspect of the invention, there is provided an agrochemical composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined according to the invention.
According to a third aspect of the invention, there is provided a method of controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined according to the invention, or a composition comprising this compound as active ingredient, to a pest, a locus of pest (preferably a plant), to a plant susceptible to attack by a pest or to plant a propagation material thereof (such as a seed). According to this particular aspect of the invention, the method may exclude methods for the treatment of the human or animal body by surgery or therapy.
According to a fourth aspect of the invention, there is provided the use of a compound according to Formula (I) as an insecticide, acaricide, nematicide or molluscicide. According to this particular aspect of the invention, the use may exclude methods forthe treatment ofthe human or animal body by surgery or therapy.
As used herein, the term "halogen" or“halo” refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo), preferably fluorine, chlorine or bromine.
As used herein, cyano means a -CN group.
As used herein, the term“hydroxyl” or“hydroxy” means an -OH group.
As used herein, amino means an -NH2 group.
As used herein, nitro means an -NO2 group.
As used herein, formyl means a -C(0)H group.
As used herein, the term "Ci-C6alkyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to six carbon atoms, and which is attached to the rest of the molecule by a single bond. Ci-C4alkyl, Ci-C3alkyl and Ci-C2alkyl are to be construed accordingly. Examples of Ci-C6alkyl include, but are not limited to, methyl, ethyl, n-propyl, 1 -methylethyl (isopropyl), n-butyl, and 1 ,1 -dimethylethyl (f-butyl). A “Ci- C4alkylene” group refers to the corresponding definition of Ci-C4alkyl, except that such radical is attached to the rest of the molecule by two single bonds. Examples of Ci-C4alkylene, are -CH2- and - CH2CH2-.
As used herein, the term "Ci-C6haloalkyl" refers to a Ci-C6alkyl radical as generally defined above substituted by one or more of the same or different halogen atoms. Examples of Ci-C6haloalkyl include, but are not limited to fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl, 2,2-difluoroethyl, 2,2,2- trifluoroethyl, and 3,3,3-trifluoropropyl.
As used herein, the term "Ci-C6alkoxy" refers to a radical of the formula RaO- where Ra is a Ci- C6alkyl radical as generally defined above. The term "Ci-C4alkoxy" should be construed accordingly. Examples of Ci-C6alkoxy include, but are not limited to, methoxy, ethoxy, propoxy, iso-propoxy, and t- butoxy.
As used herein, the term "Ci-C6haloalkoxy" refers to a Ci-C6alkoxy group as defined above substituted by one or more of the same or different halogen atoms. Ci-C4haloalkoxy is to be construed accordingly. Examples of Ci-C6haloalkoxy include, but are not limited to, fluoromethoxy, difluoro methoxy, fluoroethoxy, trifluoromethoxy, and trifluoroethoxy.
As used herein, the term "C2-C6alkenyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond that can be of either the (E)- or (^-configuration, having from two to six carbon atoms, which is attached to the rest of the molecule by a single bond. Examples of C2-C6alkenyl include, but are not limited to, prop-1 -enyl, allyl (prop-2-enyl), and but-1-enyl.
As used herein, the term "C2-C6haloalkenyl" refers to a C2-C6alkenyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term "C2-C6alkynyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond. Examples of C2-C6alkynyl include, but are not limited to, prop-1-ynyl, propargyl (prop-2-ynyl), and but-1-ynyl.
As used herein, the term "C2-C6haloalkynyl" refers to a C2-C6alkynyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term "C3-C6cycloalkyl" refers to a stable, monocyclic ring radical which is saturated or partially unsaturated and contains 3 to 6 carbon atoms. C3-C4cycloalkyl is to be construed accordingly. Examples of C3-C6cycloalkyl include, but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, cyclopenten-1-yl, cyclopenten-3-yl, and cyclohexen-3-yl.
As used herein, the term "C3-C6cycloalkylCi-C4alkyl" refers to a C3-C6cycloalkyl ring as defined above attached to the rest of the molecule by a Ci-C4alkylene radical as defined above. Examples of C3-C6cycloalkylCi-C4alkyl include, but are not limited to cyclopropyl-methyl, cyclobutyl-ethyl, and cyclopentyl-methyl.
As used herein, the term "C3-C6halocycloalkyl" refers to a C3-C6cycloalkyl ring as defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term "C3-C6halocycloalkylCi-C4alkyl" refers to a C3-C6halocycloalkyl radical as defined above attached to the rest of the molecule by a Ci-C4alkylene radical as defined above.
As used herein, the term "Ci-C4alkoxyCi-C4alkyl" refers to a radical of the formula Ry-O-R*- where Ry is a Ci-C4alkyl radical as generally defined above, and Rx is a Ci-C4alkylene radical as generally defined above.
As used herein, the term "Ci-C4haloalkoxyCi-C4alkyl" refers to a radical of the formula Ry-O-R*- where Ry is a Ci-C4alkyl radical as generally defined above substituted by one or more of the same or different halogen atoms, and Rx is a Ci-C4alkylene radical as generally defined above.
As used herein, the term "Ci-C4alkoxyCi-C4alkoxy" refers to radical of the formula R O-R>rO- where Ry is a Ci-C4alkyl radical as generally defined above, and Rx is a Ci-C4alkylene radical as generally defined above.
As used herein, the term“cyanoCi-C4alkyl” refers to a Ci-C4alkyl radical as generally defined above substituted by one or more cyano groups. CyanoCi-C2alkyl should be construed accordingly.
As used herein, the term“cyanoCi-C4haloalkyl” refers to a Ci-C6haloalkyl radical as generally defined above substituted by one or more cyano groups.
As used herein, the term“Ci-C6alkylsulfanyl” refers to a radical of the formula RxS- wherein Rx is a Ci-C6alkyl radical as generally defined above.
As used herein, the term “Ci-C6haloalkylsulfanyl” refers to a Ci-C6alkylsulfanyl radical as generally defined above substituted by one or more of the same or different halogen atoms. As used herein, the term“Ci-Cealkylsulfinyl” refers to a radical of the formula RxS(O)- wherein Rx is a Ci-C6alkyl radical as generally defined above.
As used herein, the term“Ci-Cehaloalkylsulfinyl” refers to a Ci-Cealkylsulfinyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term“Ci-C6alkylsulfonyl” refers to a radical of the formula RxS(0)2- wherein Rx is a Ci-C6alkyl radical as generally defined above.
As used herein, the term “Ci-C6haloalkylsulfonyl” refers to a Ci-C6alkylsulfonyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term " Ci-C6alkylcarbonyl" refers to a radical of the formula RxC(O)- where Rx is a Ci-C6alkyl radical as generally defined above.
As used herein, the term "Ci-C6haloalkylcarbonyl" refers to a Ci-C6alkylcarbonyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term "Ci-C6alkoxycarbonyl" refers to a radical of the formula RxOC(O)- where Rx is a Ci-C6alkyl radical as generally defined above.
As used herein, the term "Ci-C6haloalkoxycarbonyl" refers to a Ci-C6alkoxycarbonyl as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term "Ci-C6alkylcarbonylamino" refers to a radical of the formula RxC(0)N(H)- where Rx is a Ci-C6alkyl radical as generally defined above.
As used herein, the term "Ci-C6haloalkylcarbonylamino" refers to a Ci-C6alkylcarbonylamino radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term "C3-C6cycloalkylcarbonylamino" refers to a radical of the formula RxC(0)N(H)- where Rx is a C3-C6cycloalkyl radical as generally defined above.
As used herein, the term "C3-C6halocycloalkylcarbonylamino" refers to a C3-
C6cycloalkylcarbonylamino radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term“Ci-C6alkylaminocarbonyl” refers to a radical of the formula RxNHC(O)- where Rx is a Ci-C6alkyl radical as generally defined above.
As used herein, the term "Ci-C6haloalkylaminocarbonyl" refers to a Ci-C6alkylaminocarbonyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term “C3-C6cycloalkylaminocarbonyl” refers to a radical of the formula RxNHC(O)- where Rx is a C3-C6cycloalkyl radical as generally defined above.
As used herein, the term “C3-C6halocycloalkylaminocarbonyl” refers to a C3-
C6cycloalkylaminocarbonyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term“C3-C6cycloalkylcarbonyl” refers to a radical of the formula RxC(O)- where Rx is a C3-C6cycloalkyl radical as generally defined above.
As used herein, the term“C3-C6halocycloalkylcarbonyl” refers to a C3-C6cycloalkylcarbonyl radical as generally defined above substituted by one or more of the same or different halogen atoms. As used herein, the term "heteroaryl" refers to a 5- or 6-membered monocyclic aromatic ring radical which comprises 1 , 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur. The heteroaryl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom. Examples of heteroaryl include, but are not limited to, furanyl, pyrrolyl, thienyl, pyrazolyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazinyl, pyridazinyl, pyrimidyl, pyridyl, and indolyl.
As used herein, the term "heterocyclyl" or "heterocyclic" refers to a stable 5- or 6-membered non-aromatic monocyclic ring radical, which comprises 1 , 2, or 3 heteroatoms individually selected from nitrogen, oxygen and sulfur. The heterocyclyl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom. Examples of heterocyclyl include, but are not limited to, pyrrolinyl, pyrrolidyl, tetrahydrofuranyl, tetrahydrothienyl, tetrahydrothiopyranyl, piperidinyl, piperazinyl, tetrahydropyranyl, dioxolanyl, morpholinyl.
The compounds of formula (I) according to the invention, which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as Ci-C4alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as Ci-C4-alkane- or arylsulfonic acids which are unsubstituted or substituted, for example by halogen, for example methane- or p-toluenesulfonic acid. Compounds of formula (I) which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.
The presence of one or more possible asymmetric carbon atoms in a compound of Formula (I) means that the compounds may occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Also, atropisomers may occur as a result of restricted rotation about a single bond. Formula (I) is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof for a compound of Formula (I). Likewise, Formula (I) is intended to include all possible tautomers (including lactam-lactim tautomerism and keto- enol tautomerism) where present. The present invention includes all possible tautomeric forms for a compound of Formula (I).
In each case, the compounds of Formula (I) according to the invention are in free form, in oxidized form as an N-oxide, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form. N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book “Heterocyclic N-oxides” by A. Albini and S. Pietra, CRC Press, Boca Raton 1991 . The compounds of formula (I) according to the invention also include hydrates, which may be formed during salt formation.
The following list provides definitions, including preferred definitions, for substituents W, R1 , R2, m, R3a, R3b, R4 (ie, Y1 , Y2, Y3, Y4), U, Ui , U2, U3, LU and n with reference to the compounds of Formula (I) of the present invention. For any one of these substituents, any of the definitions given below may be combined with any definition of any other substituent given below or elsewhere in this document.
W is O or S. Preferably, W is O.
R1 is Ci-C6alkyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or Ci-C6haloalkyl; or C2-C6alkenyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or C2-C6haloalkenyl; or C2-C6alkynyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or C2-C6haloalkynyl; or C3-C6cycloalkyl optionally substituted by 1 or 2 substituents independently selected from U3 or a single substituent selected from U2; or cyano, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl or phenylcarbonyl.
Preferably, R1 is Ci-C6alkyl optionally substituted by 1 or 2 substituents selected from Ui or a single substituent selected from U2, or Ci-C4haloalkyl; or
C2-C6alkenyl optionally substituted by 1 or 2 substituents selected from Ui or a single substituent selected from U2, or C2-C6haloalkenyl, or
C2-C6alkynyl optionally substituted by 1 or 2 substituents selected from Ui or a single substituent selected from U2, or C2-C6haloalkynyl, or
C3-C6cycloalkyl optionally substituted by 1 or 2 substituents selected from U3; or
Ci-C4alkylcarbonyl or phenylcarbonyl; and
Ui is cyano, C3-C6cycloalkyl, Ci-C4alkoxy, C3-C4halocycloalkyl, Ci-C2alkoxy-Ci-C2alkoxy, Ci- C4alkylsulfanyl, Ci-C4alkylcarbonyl, C3-C4cycloalkylcarbonyl, Ci-C4alkoxycarbonyl, N-0(Ci-C4alkyl);
U2 is phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl or pyrazinyl, each optionally substituted by (i) 1 , 2 or 3 independently selected halogen groups, or (ii) a single L4 group selected from cyano and Ci-C4haloalkoxy; and
U3 is independently selected from halogen, Ci-C4alkyl or Ci-C4haloalkyl.
More preferably, R1 is selected from R1 is selected from Ci-C6alkyl, Ci-C6haloalkyl, cyanoCi-C4alkyl, Ci-C2alkoxy-Ci-C4alkyl, Ci-C2alkoxy-Ci-C2alkoxy-Ci-C2alkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C4alkynyl, C3-C6cycloalkyl, (C3-C6cycloalkyl)methyl, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci- C4alkoxycarbonylCi-C3alkyl, Ci-C4alkylcarbonylCi-C2alkyl, Ci-C2alkylsulfanylCi-C4alkyl, cyclopropyiC(0)methyl, (halocyclopropyl)methyl, -CH(C(0)0Ci-C4alkyl)2, (Ci-C4alkyl-0-N=)Ci-C4alkyl, (Ci-C4alkyl-0-N=)Ci-C4alkyl, phenylaminocarbonylCi-C4alkyl wherein the phenyl group is optionally substituted by 1 , 2 or 3 halogen atoms, or (phenyl)methyl, (thienyl)methyl, (pyridinyl)methyl, or (pyrazinyl)methyl, wherein each phenyl, thienyl, pyridinyl or pyrazinyl group is optionally substituted by a single group selected from chloro, fluoro, cyano, methyl, ethyl, ethoxy, difluoromethoxy or trifluoromethoxy.
Still more preferably, R1 is selected from Ci-C4alkyl, Ci-C6haloalkyl, cyanoCi-C4alkyl, Ci-C2alkoxy- Ci-C2alkyl, Ci-C2alkoxy-Ci-C2alkoxy-Ci-C2alkyl, C2-C6alkenyl, C2-C4fluoroalkenyl, C2-C4alkynyl, C3- C4cycloalkyl, (C3-C4cycloalkyl)methyl, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci- C4alkoxycarbonylCi-C3alkyl, Ci-C4alkylcarbonylCi-C2alkyl, Ci-C2alkylsulfanylCi-C4alkyl, cyclopropylC(0)methyl, (difluorocyclopropyl)methyl, -CH(C(0)0Ci-C4alkyl)2, (Ci-C4alkyl-0-N=)Ci- C4alkyl, (Ci-C4alkyl-0-N=)Ci-C4alkyl, phenylaminocarbonylCi-C4alkyl wherein the phenyl group is optionally substituted by 1 , 2 or 3 independently selected chloro or fluoro atoms, or (phenyl)methyl, (thien-2-yl)methyl, (pyridin-2-yl)methyl, or (pyrazinyl)methyl, wherein each phenyl, thienyl, pyridinyl or pyrazinyl group is optionally substituted by a single group selected from chloro, fluoro, cyano, methyl, ethyl, ethoxy, difluoromethoxy or trifluoromethoxy.
Still further preferably, R1 is selected from -CFhCECH, -CH2CF2H, cyclopropyl, -CF2H, -CH2CH2CN, -CH2CN, (2,2-difluorocyclopropyl)methyl, -CH2C(0)cyclopropyl, -CF2CF2H, -CH2CF2H, -CF2H, - CH2CF3, -C(0)0t-Bu, -CH2CH2F, -CH2CH2CH2CF3, -CH2CH2OCH2OCH3, -CH2CH2CH2OCH2CH3, - CH(C02CH3)2, (5-cyanothien-2-yl) methyl, -CH2C(0)(CH2)3CH3, -CH2(CH2)3CFCF2,
CH(CH3)C(0)0CH2CH3, -CH2CH2CHC=(CH3)2, -CH2CH2OCH2CH2OCH3, -CH2CH2CH2SCH3, - CH2C(CH3)=CH2, -CH2CH=CH2, -CH2C(0)t-Bu, (3-trifluoromethoxyphenyl)methyl, (3- difluoromethoxyphenyl)methyl, (cyclobutyl)methyl, -CH2CH2CI, (5-fluoropyridin-2-yl)methyl, (pyrazinyl)methyl, -CH2CH2CH=CH2, -CFhCFhCFhCF^CFh, -CH(CH3)C(H)=NOCH2CH3, CH2C(CH3)=NOCH3, -CH(CH3)C(0)NH(3-CF3Ph), -CH2CH2CH2CI, -CH2CH3, or -CH2C(0)cyclopropyl.
Most preferably, R1 is selected from -CH2CºCH, cyclopropyl, -CF2H, -CH2CN, (2,2- difluorocyclopropyl)methyl, -CF2CF2H, -CH2CF2H, -CH2CF3, -C(0)0tBu, -CH2CH2F, CH2CH2CH2CF3, -CH2CH=CH2, (3-trifluoromethoxyphenyl)methyl, (3-difluoromethoxyphenyl)methyl or -CH2CH3.
Ui is nitro, cyano, amino, hydroxyl, CO2H, C3-C6cycloalkyl, C3-C6halocycloalkyl, Ci-C4alkoxy, Ci- C4haloalkoxy, Ci-C2alkoxy-Ci-C2alkoxy, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci- C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci- C4alkoxycarbonyl, Ci-C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl, C3-C4cycloalkylcarbonyl, =N- 0(Ci-C4alkyi), =N-0(Ci-C4haloaikyl), -Si(Ci-C4alkyl)3, (Ci-C4haloalkyl)NH-, (Ci-C4haloalkyl)2N-, (C1-C4 haloalkyl)(Ci-C4alkyl)N-, (Ci-C4alkyl)NH-, (Ci-C4alkyl)2N-, (C3-C6cycloalkyl)NH-, (C3-C6cycloalkyl)(Ci- C4alkyl)N-, Ci-C4alkylcarbonylamino, Ci-C4haloalkylcarbonylamino, aminocarbonyl, N-Ci- C4alkylaminocarbonyl, (N,N-di-Ci-C4alkylamino)carbonyl, C3-C6cycloalkylaminocarbonyl, Ci- C4haloalkylaminocarbonyl, C3-C6halocycloalkylaminocarbonyl or phenylaminocarbonyl, wherein the phenyl group is optionally substitued by a single substituent selected from halogen (eg, chloro or fluoro), methyl, methoxy or trifluoromethyl.
U2 is phenyl, heteroaryl wherein the heteroaryl moiety is a 5- or 6-membered monocyclic aromatic ring which comprises 1 , 2, 3, or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur, or a 5- or 6-membered saturated or partially saturated heterocyclic ring wherein the heterocyclic ring comprises 1 to 3 heteroatoms selected from nitrogen, oxygen and sulfur, and wherein each phenyl, heteroaryl or heterocyclic ring is optionally substituted by: (i) 1 , 2, 3, 4 or 5 independently selected halogen groups, or (ii) 1 or 2 groups independently selected from L4 and optionally a halogen group.
Preferably, U2 is phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl or pyrazinyl, each optionally substituted by (i) 1 , 2 or 3 independently selected halogen groups, or (ii) a single L4 group selected from cyano and Ci-C4haloalkoxy. More preferably, U2 is phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl or pyrazinyl, each optionally substituted by (i) a single fluoro, chloro or bromo group, or (ii) a single L4 group selected from cyano or Ci-C2haloalkoxy (eg, difluoromethoxy or trifluoro methoxy).
L is halogen, nitro, cyano, amino, hydroxyl, -CO2H, Ci-C4alkyl, Ci-C4haloalkyl, C3-C6cycloalkyl, C3- Cehalocycloalkyl, C3-C6halocycloalkyl-Ci-C4alkyl, C3-C6cycloalkyl-Ci-C4alkyl, Ci-C4alkoxy, Ci-C4alkoxy- Ci-C4alkyl, Ci-C4haloalkoxy, Ci-C4haloalkoxy-Ci-C4alkyl, cyano-Ci-C4alkyl, cyano-Ci-C4haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C2-C6haloalkynyl, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci- C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci-C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl and -C(0)NH2.
Preferably, U3 is selected from halogen, Ci-C4alkyl or Ci-C4haloalkyl. More preferably, U3 is selected from fluoro, chloro, bromo, methyl, ethyl, trifluoromethyl.
U4 is nitro, cyano, amino, hydroxyl, -SCN, -CO2H, Ci-C4alkyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C3-C6cycloalkyl-Ci-C4alkyl, C3-C6halocycloalkyl-Ci-C4alkyl, Ci-C4haloalkyl, Ci-C4alkoxy, Ci-C4alkoxy- Ci-C4alkyl, Ci-C4alkoxy-Ci-C4alkoxy, cyano-Ci-C4alkyl, cyano-Ci-C4haloalkyl, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, Ci-C4haloalkoxy, Ci-C4haloalkoxy-Ci-C4alkyl, Ci- C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci-C4haloalkylcarbonyl, Ci- C4haloalkoxycarbonyl, (Ci-C4alkyl)NH-, (Ci-C4alkyl)2N-, (C3-C6cycloalkyl)NH-, (C3-C6cycloalkyl)2N-, Ci- C4alkylcarbonylamino, C3-C6cycloalkylcarbonylamino, Ci-C4haloalkylcarbonylamino, C3- Cehalocycloalkylcarbonylamino, Ci-C4alkylaminocarbonyl, C3-C6 cycloalkylaminocarbonyl, Ci- C4haloalkylaminocarbonyl, C3-C6halocycloalkylaminocarbonyl, C3-C6 cycloalkylcarbonyl, C3-C6 halocycloalkylcarbonyl, -SFs or -C(0)NH2. m is 0, 1 or 2. In some embodiments of the invention, m is 0. In some embodiments of the invention, m is 1 . In some embodiments of the invention, m is 2. Preferably, m is 0 or 1 , and more preferably, m is 0.
R2 is independently selected from halogen, cyano, amino, hydroxyl, Ci-C4alkyl, Ci-C4haloalkyl, Ci- C4haloalkoxy, Ci-C4alkoxy, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, C1-C4 alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl and cyclopropyl. Preferably, R2 is independently selected from fluoro, chloro, methyl, ethyl, trifluoromethyl, trifluoromethoxy, methoxy or ethoxy. Still more preferably, R2 is methyl, in particular, when n is 1 .
R3a and R3b are independently selected from hydrogen, halogen, Ci-C4alkyl, Ci-C4haloalkyl, Ci- C4alkoxy, Ci-C4haloalkoxy and cyano. Preferably, R3a is hydrogen and R3b is selected from hydrogen, chloro, fluoro, methyl, ethyl, trifluoromethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, methoxy or ethoxy. More preferably, R3a is hydrogen and R3b is hydrogen or methyl. Most preferably, R3a is hydrogen and R3b is hydrogen.
R4 is selected from one of Y1 to Y4;
Figure imgf000012_0001
wherein, n is 0, 1 or 2. Preferably, n is 0 or 1 , and more preferably, n is 1 .
U is independently selected from halogen, cyano, nitro, hydroxyl, amino, Ci-C4alkyl, Ci-C4haloalkyl, Ci-C4alkoxy, Ci-C4haloalkoxy, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, Ci- C4haloalkoxy-Ci-C4alkyl, Ci-C4alkoxy-Ci-C4alkyl, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci- C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, formyl, cyclopropyl, Ci-C4alkylcarbonyl or C3-C6cycloalkylcarbonyl. Preferably, U is independently selected from halogen, cyano, nitro, hydroxyl, amino, methyl, ethyl, trifluoromethyl, methoxy, ethoxy. Most preferably, U is independently selected from fluoro, chloro and trifluoromethyl, and is in particular, chloro.
In some preferred embodiments of the invention, R4 is selected from one of Y2 or Y3. In one embodiment of the invention, R4 is Y2. In another embodiment of the invention, R4 is Y3.
In certain embodiments of the present invention, the compound of Formula (I) is:
Figure imgf000013_0001
wherein R1 is defined in accordance with the present invention, and X represents hydrogen or R2 as methyl.
In certain embodiments of the present invention, the compound of Formula (I) is:
Figure imgf000013_0002
wherein R1 is defined in accordance with the present invention, and X represents hydrogen or R2 as methyl.
Preferably, the compound according to Formula (I) is selected from a compound 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below).
Compounds of the present invention can be made as shown in the following schemes 1 to 5, in which, unless otherwise stated, the definition of each variable is as defined herein for a compound of formula (I).
Compounds of formula (la), wherein R1 , R2, R3a, R3b R4 and m as defined herein can be readily prepared. A typical example of such a synthesis is shown in Scheme 1 below.
Figure imgf000013_0003
Scheme 1
Compounds of formula (la) where R1 is as described in compounds of formula (I) may be prepared from compounds of formula (II), wherein R2, R3a, R3b R4 and m are defined as for formula (I), by N-alkylation with R1-XLG, wherein R1 is as described for formula (I) above and wherein XLG is a leaving group such as halogen (preferably iodide, bromide or chloride), in the presence of a base, such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride in an appropriate solvent such as N,N-dimethylformamide, N,N-dimethylacetamide or acetonitrile. Such alkylation is well- known from the literature, for example, by analogy from European Journal of Organic Chemistry 2002 (1 1), 1763-1769. In these types of reaction, often an O-alkylation product is obtained as a by-product.
Compounds of formula (II), wherein R2, R3a, R3b R4 and m are as defined in accordance with the present invention, are generally known or can be readily prepared by those skilled in the art. A typical example of such a synthesis is shown in Scheme 2.
Figure imgf000014_0001
For example, compounds of formula (II) wherein R2, R3a, R3b, R4 and m are as defined for formula (I), may be prepared by the reaction of a compound of formula (III) and a compound of formula (IV), wherein LG is a leaving group such as, for example, halide, in the presence, or not, of a suitable base, such as for example sodium carbonate, potassium carbonate or cesium carbonate, or lithium alkoxide, sodium alkoxide or potassium alkoxide, in suitable solvents that may include, for example, acetonitrile, DMF, 1 ,4-dioxane, and usually upon heating of the reaction mixture at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture, optionally under microwave heating conditions. A catalyst may be used in this reaction, including sodium iodide or tert-butylammonium iodide.
Compounds of formula (III) are commercially available or can be readily prepared by those skilled in the art. Many examples can be found in the literature, for example, see Mendeleev Communications 2016, 26(1), pp 69-71 and cited references therein; Bulletin of the Chemical Society of Japan 1987, 60(5), pp 1793-9; Journal of Heterocyclic Chemistry 1985, 22(4), pp 1061 -4; Heterocycles (2002), 57(12), pp 2335-2343.
Otherwise, the compounds of Formula (III) could be prepared as described in Scheme 2. Specifically, compounds of formula (III) wherein R2 and m are defined as forformula (I) may be prepared by a Curtius rearrangement from compounds of formula (X) which are commercially available, wherein R2 and m are as described for formula (I), by treatment with diphenylphosphoryl azide (DPPA), in the presence of a suitable base, such as for example trimethylamine, in suitable solvents that may include, for example, ethanol, tert-butanol, 1 ,4-dioxane, tetrahydrofuran, usually upon heating at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture. Such syntheses have been described previously, for example, in J Med Chem, 58(20), 8066- 8096, 2015. Alternatively, other compounds to formula (X) could be used such as, for example, analogues of 3-aminopicolinic acid.
Alternatively, compounds of formula (II) wherein R2, R3a, R3b, R4 and m are defined as forformula (I) can be prepared by the reaction of compounds of formula (V) and compounds of formula (VI), wherein LGi and LG2 are independently leaving groups, such as, for example, halide, an aryloxy group or imidazolyl group. The reaction can be performed at 0°C to the boiling point of the solvent and preferably in the presence, or not, of a base, which may be, for example, ammonia, pyridine, Hiinig’s base, triethylamine or sodium carbonate and in a solvent such as, for example, dichloromethane or a mixture of solvents, such as methanol and dichloromethane Such processes have been described previously, for example, in J Med Chem 2015, 58, p 8066; J Het Chem. 2010, 47, p 683; Synth Comm 1982, 12, p 213.
Alternatively, compounds of formula (II) wherein R2, R3a, R3b, R4 and m are defined as forformula (I) can be prepared by the reaction of compounds of formula (V) and compounds of formula (VI), wherein LGi and LG2 are identical, such as, for example urea. The reaction can be performed at 50°C to 200°C or to the boiling point of the reaction mixture and in the presence or not of a solvent such as dimethyl formamide or tetrahydrofuran. Similar processes have been described previously, for example, in J Med Chem, 32(7), 1566-71 ; 1989, Chemistry of Heterocyclic Compounds (New York, NY, United States), 48(12), 1801 -1804; 2013, Organic Letters, 15(7), 1456-1459; 2013 or J Med Chem, 51 (4), 875-896; 2008. Compounds of formula (V), wherein R2, R3a, R3b, R4 and m are as defined for the present invention, are generally known or can be readily prepared by those skilled in the art. A typical example of such a synthesis is shown in Scheme 3.
Figure imgf000016_0001
Scheme 3
Compounds of formula (V) wherein R2, R3a, R3b, R4 and m are defined as for formula (I) may be prepared by the hydrolysis of compounds of formula (IX) by treatment with a suitable strong acid, such as, for example a 37% concentrated aqueous solution of HCI, usually upon heating at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture, and optionally under microwave heating conditions.
Alternatively, compounds of formula (V) wherein R2, R3a, R3b R4 and m are defined as forformula (I) may be prepared by the hydrolysis of compounds of formula (VIII), by treatment with a suitable strong acid, like, for example a 37% concentrated aqueous solution of hydrogen bromide, usually upon heating at temperatures between room temperature and 200°C, preferably between 20°C to the boiling point of the reaction mixture, and optionally under microwave heating conditions.
Compounds of formula (IX) wherein R2, R3a, R3b R4 and m are defined as for formula (I), may be prepared by hydrolysis of compounds of formula (VIII) by treatment with a suitable acid, such as, for example trifluoroacetic acid (TFA), in suitable solvents that may include, for example, dichloromethane or 1 ,2-dichloroethane, and usually upon heating at temperatures between room temperature and 200°C, preferably between 20°C to the boiling point of the reaction mixture, optionally under microwave heating conditions.
Compounds of formula (VIII) wherein R2, R3a, R3b R4 and m are as defined for formula (I), may be prepared by reaction between compounds of formula (VII) and compounds of formula (IV), wherein LG is a leaving group such as, for example, halide, in the presence, or not, of a suitable base, such as for example sodium carbonate, potassium carbonate or cesium carbonate, or lithium ethanoate, sodium ethanoate or potassium ethanoate, in suitable solvents that may include, for example, acetonitrile, DMF, 1 ,4-dioxane, and usually upon heating at temperatures between room temperature and 200°C, preferably between 20°C to the boiling point of the reaction mixture, and optionally under microwave heating conditions.
Compounds of formula (VII), wherein R2 and m are as defined for the present invention, are generally known or can be readily prepared by those skilled in the art. A typical example of such a synthesis is shown in Scheme 4.
Figure imgf000017_0001
Scheme 4
For example, compounds of formula (VII) wherein R2 and m are defined as for formula (I) may be prepared from compounds of formula (XII) by treatment with, for example, di-tert-butyl dicarbonate ((BOC)20), in a suitable solvent that may include, for example, dichloromethane, 1 ,2-dichloroethane, tetrahydrofuran or by performing the reaction in molten di-tert-butyl dicarbonate, usually upon heating at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture. An alternative protecting group could be used such as, eg, benzyl. Compounds of formula (XII) may be prepared by the reaction of compounds of formula (XI) and compounds of formula (XIII), wherein LGi and LG2 are independently from each other leaving groups, like, for example amino, halide or imidazole. The reaction can be performed at 0°C to the boiling point of the solvent and preferably in the presence of a base, which could be, for example, pyridine, Hiinig’s base, triethylamine or sodium carbonate. Such processes have been described previously, Eur. J. Med. Chem. 2016, 1 13, p 102.
Compounds of formula (XI) are commercially available or can be readily prepared by those skilled in the art. Scheme 5
Alternatively, compounds of formula (I) wherein R1 , R2, R3a, R3b R4 and m are as defined for formula (I), may be prepared by a reaction between a compound of formula (XV) and a compound of formula (IV), wherein LG is a leaving group such as, for example, chloride, in the presence, or not, of a suitable base, such as for example potassium carbonate or cesium carbonate or lithium alkoxide, in suitable solvents that may include, for example, acetonitrile, DMF, 1 ,4-dioxane, and usually upon heating of the reaction mixture at temperatures between room temperature and 200°C, and preferably between 20°C to the boiling point of the reaction mixture, optionally under microwave heating conditions.
Compounds of formula (XV) wherein R2, R1 and m are defined as for formula (I) can be prepared by the reaction of compounds of formula (XIV) and compounds of formula (VI), wherein LGi and LG2 are independently from each other leaving groups, such as, for example, halide such as chloride, an aryloxy group or imidazolyl. The reaction can be performed at 0°C to the boiling point of the solvent and preferably in the presence of a base, which may be, for example, pyridine, Hiinig’s base, triethylamine or sodium carbonate. Such processes have been described previously, for example, in Journal of Heterocyclic Chemistry 1985, 22(4), 1061 -4; Bioorganic & Medicinal Chemistry Letters 2015, 25(5), 1 1 17-1 123; Journal of Heterocyclic Chemistry 1987 24(6), 1709-16; or J Med Chem 2012, 55(2), 852- 870.
Alternatively, compounds of formula (XV) wherein R2, R3a, R3b, R4 and m are defined as for formula (I) can be prepared by the reaction of compounds of formula (XIV) and compounds of formula (VI), wherein LGi and LG2 are identical such as, for example urea. The reaction can be performed at 50°C to 200°C or to the boiling point of the reaction mixture. In presence or not of a solvent such as dimethyl formamide or tetrahydrofuran. Similar processes have been described previously, for example, in J Med Chem, 32(7), 1566-71 ; 1989, Chemistry of Heterocyclic Compounds (New York, NY, United States), 48(12), 1801 -1804; 2013, Organic Letters, 15(7), 1456-1459; 2013 or J Med Chem, 51 (4), 875-896; 2008.
Compounds of formula (XIV) are commercially available or can be readily prepared by those skilled in the art. Many examples can be found in literature, for example, see Australian Journal of Chemistry 2016, 69(6), 618-630; Bioorganic & Medicinal Chemistry Letters 2008, 18(20), 5493-5496; Bioorganic & Medicinal Chemistry Letters 2015 25(5), 1 1 17-1 123;, ARKIVOC (Gainesville, FL, United States) 2002 (10), 90-96; or Synlett, 23(12), 1816-1820; 2012.
In accordance with the reactions described in any of Schemes 1 to 5, examples of suitable bases may include alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines. Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N- diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1 ,8-diazabicyclo[5.4.0]undec-7-ene (DBU).
The reactants can be reacted with each other as such, i.e. without adding a solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture of these. If the reaction is carried out in the presence of a base, bases which are employed in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also act as solvents or diluents.
Reactions are advantageously carried out in a temperature range from approximately -80 °C to approximately 140 °C, preferably from approximately -30 °C to approximately 100 °C, in many cases in the range between ambient temperature and approximately 80 °C.
A compound of formula (I) can be converted in a manner known per se into another compound of formula (I) by replacing one or more substituents of the starting compound of formula (I) in the customary manner by (an)other substituent(s) according to the invention.
Depending on the choice of the reaction conditions and starting materials which are suitable in each case, it is possible, for example, in one reaction step only to replace one substituent by another substituent according to the invention, or a plurality of substituents can be replaced by other substituents according to the invention in the same reaction step.
Salts of compounds of formula (I) can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds of formula (I) are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.
Salts of compounds of formula (I) can be converted in the customary manner into the free compounds (I), acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent. Salts of compounds of formula (I) can be converted in a manner known per se into other salts of compounds of formula (I), acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
Depending on the procedure or the reaction conditions, the compounds of formula (I), which have salt-forming properties, can be obtained in free form or in the form of salts.
The compounds of formula (I) and, where appropriate, the tautomer’s thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule, the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and herein below, even when stereochemical details are not mentioned specifically in each case.
Diastereomeric mixtures or racemic mixtures of compounds of formula (I), in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diastereomers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.
Enantiomeric mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl cellulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be set free by the action of suitable agents, for example basic agents.
Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.
It is advantageous to isolate or synthesize in each case the biologically more effective isomer, for example enantiomer or diastereomer, or isomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity. The compounds of formula (I) and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.
The compounds of formula (I) according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and may be well-tolerated by warm-blooded species, fish and plants. The compounds of formula (I) may have a beneficial safety profile towards non-target species, such as bees, and accordingly a good toxicity profile. The active ingredients according to the invention may act against all or individual developmental stages of normally sensitive, but also resistant pests, such as insects or representatives of the order Acarina. The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate.
Examples of the above-mentioned pests are:
from the order Acarina, for example,
Acalitus spp., Aculus spp., Acaricalus spp., Aceria spp., Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp., Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp., Eotetranychus spp., Eriophyes spp., Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Olygonychus spp., Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp., Polyphagotarsonemus spp., Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp., Tarsonemus spp. and Tetranychus spp.,
from the order Anoplura, for example,
Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp., from the order Coleoptera, for example,
Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp., Astylus atromaculatus, Ataenius spp., Atomaria linearis, Chaetocnema tibialis, Cerotoma spp., Conoderus spp., Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp., Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa decemLineata, Lissorhoptrus spp., Liogenys spp., Maecolaspis spp., Maladera castanea, Megascelis spp., Melighetes aeneus, Melolontha spp., Myochrous armatus, Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp., Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Somaticus spp., Sphenophorus spp., Sternechus subsignatus, Tenebrio spp., Tribolium spp. and Trogoderma spp., from the order Diptera, for example, Aedes spp., Anopheles spp., Antherigona soccata,_Bactrocea oleae, Bibio hortulanus, Bradysia spp., Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp., Drosophila melanogaster, Fannia spp., Gastrophilus spp., Geomyza tripunctata, Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp., Rivelia quadrifasciata, Scatella spp., Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.,
from the order Hemiptera, for example,
Acanthocoris scabrator, Acrosternum spp., Adelphocoris lineolatus, Amblypelta nitida, Bathycoelia thalassina, Blissus spp., Cimex spp., Clavigralla tomentosicollis, Creontiades spp., Distantiella theobroma, Dichelops furcatus, Dysdercus spp., Edessa spp., Euchistus spp., Eurydema pulchrum, Eurygaster spp., Euschistus spp. (stinkbugs), Halyomorpha halys, Horcias nobilellus, Leptocorisa spp., Lygus spp., Margarodes spp., Murgantia histrionic, Neomegalotomus spp., Nesidiocoris tenuis, Nezara spp., Nysius simulans, Oebalus insularis, Piesma spp., Piezodorus spp., Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophara spp., Thyanta spp., Triatoma spp., Vatiga illudens, Acyrthosium pisum, Adalges spp., Agalliana ensigera, Agonoscena targionii, Aleurodicus spp., Aleurocanthus spp., Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp., Brachycaudus spp., Brevicoryne brassicae, Cacopsylla spp., Cavariella aegopodii Scop., Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Cicadella spp., Cofana spectra, Cryptomyzus spp., Cicadulina spp., Coccus hesperidum, Dalbulus maidis, Dialeurodes spp., Diaphorina citri, Diuraphis noxia, Dysaphis spp., Empoasca spp., Eriosoma larigerum, Erythroneura spp., Gascardia spp., Glycaspis brimblecombei, Hyadaphis pseudobrassicae, Hyalopterus spp., Hyperomyzus pallidus, Idioscopus clypealis, Jacobiasca lybica, Laodelphax spp., Lecanium corni, Lepidosaphes spp., Lopaphis erysimi, Lyogenys maidis, Macrosiphum spp., Mahanarva spp., Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp., Neotoxoptera sp, Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp., Phorodon humuli, Phylloxera spp., Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saissetia spp., Scaphoideus spp., Schizaphis spp., Sitobion spp., Sogatella furcifera, Spissistilus festinus, Tarophagus Proserpina, Toxoptera spp., Trialeurodes spp., Tridiscus sporoboli, Trionymus spp., Trioza erytreae7 Unaspis citri, Zygina flammigera, Zyginidia scutellaris,
from the order Hymenoptera, for example,
Acromyrmex, Arge spp., Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplo- campa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Pogonomyrmex spp., Slenopsis invicta, Solenopsis spp. and Vespa spp.,
from the order Isoptera, for example, Coptotermes spp., Corniternes cumulans, Incisitermes spp., Macrotermes spp., Mastotermes spp., Microtermes spp., Reticulitermes spp., Solenopsis geminate
from the order Lepidoptera, for example,
Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Anticarsia gemmatalis, Archips spp., Argyresthia spp., Argyrotaenia spp., Autographa spp., Bucculatrix thurberiella, Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo spp., Choristoneura spp., Chrysoteuchia topiaria, Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Colias lesbia, Cosmophila flava, Crambus spp., Crocidolomia binotalis, Cryptophlebia leucotreta, Cydalima perspectalis, Cydia spp., Diaphania perspectalis, Diatraea spp., Diparopsis castanea, Earias spp., Eldana saccharina, Ephestia spp., Epinotia spp., Estigmene acrea, Etiella zinckinella, Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia jaculiferia, Gra- pholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Herpetogramma spp., Hyphantria cunea, Keiferia lycopersicella, Lasmopalpus lignosellus, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Loxostege bifidalis, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Mythimna spp., Noctua spp., Operophtera spp., Orniodes indica, Ostrinia nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Papaipema nebris, Pectinophora gossypiela, Perileucoptera coffeella, Pseudaletia unipuncta, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Pseudoplusia spp., Rachiplusia nu, Richia albicosta, Scirpophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Sylepta derogate, Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusia ni, Tuta absoluta, and Yponomeuta spp.,
from the order Mallophaga, for example,
Damalinea spp. and Trichodectes spp.,
from the order Orthoptera, for example,
Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp., Scapteriscus spp., and Schistocerca spp.,
from the order Psocoptera, for example,
Liposcelis spp.,
from the order Siphonaptera, for example,
Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis,
from the order Thysanoptera, for example,
Calliothrips phaseoli, Frankliniella spp., Heliothrips spp., Hercinothrips spp., Parthenothrips spp., Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp.,
from the order Thysanura, for example, Lepisma saccharina.
The active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests. Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum, beet, such as sugar or fodder beet, fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries, leguminous crops, such as beans, lentils, peas or soya, oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts, cucurbits, such as pumpkins, cucumbers or melons, fibre plants, such as cotton, flax, hemp or jute, citrus fruit, such as oranges, lemons, grapefruit or tangerines, vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers, Lauraceae, such as avocado, Cinnamonium or camphor, and also tobacco, nuts, coffee, eggplants, sugarcane, tea, pepper, grapevines, hops, the plantain family, latex plants and ornamentals.
The active ingredients according to the invention may especially be suitable for controlling Aphis craccivora, Diabrotica balteata, Thrips tabaci, Euschistus heros, Heliothis virescens, Myzus persicae, Plutella xylostella and Spodoptera littoralis in cotton, vegetable, maize, rice and soya crops. The active ingredients according to the invention are further especially suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca (preferably in vegetables, vineyards), Leptinotarsa (preferably in potatos) and Chilo supressalis (preferably in rice).
In a further aspect, the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species, cyst-forming nematodes, Globodera rostochiensis and other Globodera species, Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species, Seed gall nematodes, Anguina species, Stem and foliar nematodes, Aphelenchoides species, Sting nematodes, Belonolaimus longicaudatus and other Belonolaimus species, Pine nematodes, Bursaphelenchus xylophilus and other Bursaphelenchus species, Ring nematodes, Criconema species, Criconemella species, Criconemoides species, Mesocriconema species, Stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus species, Awl nematodes, Dolichodorus species, Spiral nematodes, Heliocotylenchus multicinctus and other Helicotylenchus species, Sheath and sheathoid nematodes, Hemicycliophora species and Hemicriconemoides species, Hirshmanniella species, Lance nematodes, Hoploaimus species, false rootknot nematodes, Nacobbus species, Needle nematodes, Longidorus elongatus and other Longidorus species, Pin nematodes, Pratylenchus species, Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species, Burrowing nematodes, Radopholus similis and other Radopholus species, Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis and other Rotylenchus species, Scutellonema species, Stubby root nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species, Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species, Citrus nematodes, Tylenchulus species, Dagger nematodes, Xiphinema species, and other plant parasitic nematode species, such as Subanguina spp., Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp., and Quinisulcius spp..
The compounds of the invention may also have activity against the molluscs. Examples of which include, for example, Ampullariidae, Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus), Bradybaenidae (Bradybaena fruticum), Cepaea (C. hortensis, C. Nemoralis), ochlodina, Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum), Discus (D. rotundatus), Euomphalia, Galba (G. trunculata), Helicelia (H. itala, H. obvia), Helicidae Helicigona arbustorum), Helicodiscus, Helix (H. aperta), Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus), Lymnaea, Milax (M. gagates, M. marginatus, M. sowerbyi), Opeas, Pomacea (P. canaticulata), Vallonia and Zanitoides.
Compounds according to Formula (I) may find utility in controlling resistant populations of insects previously sensitive to the neonicotinoid class of pesticidal (insecticidal) agents (the “neonicotinoids”). Accordingly, the present invention may relate to a method of controlling insects which are resistant to a neonicotinoid insecticide comprising applying a compound of Formula (I) (eg, a single compound selected from compounds 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below)) to a neonicotinoid-resistant insect. Likewise, the present invention may relate to the use of a compound of Formula (I) (eg, a single compound selected from compounds 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below) as an insecticide against neonicotinoid-resistant insects. Such neonicotinoid-resistant insects may include insects from the order Lepidoptera or Hemiptera, in particular from the family Aphididae.
The neonicotinoids represent a well-known class of insecticides introduced to the market since the commercialization of pyrethroids (Nauen & Denholm, 2005: Archives of Insect Biochemistry and Physiology 58:200-215) and are extremely valuable insect control agents, not least because they had exhibited little or no cross- resistance to older insecticide classes, which suffer markedly from resistance problems. However, reports of insect resistance to the neonicotinoid class of insecticides are on the increase.
The increase in resistance of such insects to neonicotinoid insecticides thus poses a significant threat to the cultivation of a number of commercially important crops, fruits and vegetables, and there is thus a need to find alternative insecticides capable of controlling neonicotinoid resistant insects (i.e. to find insecticides that do not exhibit any cross- resistance with the neonicotinoid class).
Resistance may be defined as“a heritable change in the sensitivity of a pest population that is reflected in the repeated failure of a product containing an insecticidal active ingredient to achieve the expected level of control when used according to the label recommendation for that pest species” (IRAC). Cross- resistance occurs when resistance to one insecticide confers resistance to another insecticide via the same biochemical mechanism. This can happen within insecticide chemical groups or between insecticide chemical groups. Cross- resistance may occur even if the resistant insect has never been exposed to one of the chemical classes of insecticide.
Two of the major mechanisms for neonicotinoid resistance include:- (i) Target site resistance, whereby resistance is associated with replacement of one or more amino acids in the insecticide target protein (i.e. the nicotinic acetylcholine receptor); and
(ii) Metabolic resistance, such as enhanced oxidative detoxification of neonicotinoids due to overexpression of monooxygenases;
For general review on insect resistance to neonicotinoid insecticides see, for example, Pesticide Biochemistry and Physiology (2015), 121 , 78-87 or Advances in Experimental Medicine and Biology (2010), 683(lnsect Nicotinic Acetylcholine Receptors), 75-83.
The cytochrome P450 monooxygenases are an important metabolic system involved in the detoxification/activation of xenobiotics. As such, P450 monooxygenases play an important role in insecticide resistance. P450 monooxygenases have such a phenomenal array of metabolisable substrates because of the presence of numerous P450s (60-1 1 1) in each species, as well as the broad substrate specificity of some P450s. Studies of monooxygenase-mediated resistance have indicated that resistance can be due to increased expression of one P450 (via increased transcription) involved in detoxification of the insecticide and might also be due to a change in the structural gene itself. As such, metabolic cross-resistance mechanisms affect not only insecticides from the given class (e.g. neonicotinoids) but also seemingly unrelated insecticides. For example, cross- resistance relationships between the neonicotinoids and pymetrozine in Bemisia tabaci have been reported by Gorman et al (Pest Management Science 2010, p.1 186-1 190). Or for example, for evidence on detoxification via P450, see, for example, Harrop, Thomas WR and al. Pest Management Science (2018), 74(7), p1616- 1622 and cited references.
Target site resistance of nicotinoids is well studied and it has been shown that modification of the active site of nicotinic acetylcholine receptor confers the resistance to nicotinoids. For example, see Bass et al BMC Neuroscience (201 1), 12, p 51 , Pest Management Science (2018), 74(6), 1297-1301 .
The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from Bacillus cereus or Bacillus popilliae, or insecticidal proteins from Bacillus thuringiensis, such as 5-endotoxins, e.g. CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A, or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus, toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins, toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins, agglutinins, proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors, ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin, steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP- glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.
In the context of the present invention there are to be understood by 5-endotoxins, for example CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ). Truncated toxins, for example a truncated CrylAb, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G- recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.
The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651 .
The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera).
Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a Cryl Ab toxin), YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin), YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin), Starlink® (maize variety that expresses a Cry9C toxin), Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium), NuCOTN 33B® (cotton variety that expresses a CrylAc toxin), Bollgard I® (cotton variety that expresses a Cryl Ac toxin), Bollgard II® (cotton variety that expresses a Cryl Ac and a Cry2Ab toxin), VipCot® (cotton variety that expresses a Vip3A and a CrylAb toxin), NewLeaf® (potato variety that expresses a Cry3A toxin), NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt1 1 corn borer (CB) trait) and Protecta®.
Further examples of such transgenic crops are:
1 . Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer ( Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated CrylAb toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer ( Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a CrylAb toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
3. MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/ES/96/02.
6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1 160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1 F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.
7. NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 c MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
Transgenic crops of insect-resistant plants are also described in BATS (Zentrum fiir Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003, (http://bats.ch).
The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818 and EP-A-0 353 191 . The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Crops may also be modified for enhanced resistance to fungal (for example Fusarium, Anthracnose, or Phytophthora), bacterial (for example Pseudomonas) or viral (for example potato leafroll virus, tomato spotted wilt virus, cucumber mosaic virus) pathogens.
Crops also include those that have enhanced resistance to nematodes, such as the soybean cyst nematode.
Crops that are tolerance to abiotic stress include those that have enhanced tolerance to drought, high salt, high temperature, chill, frost, or light radiation, for example through expression of NF-YB or other proteins known in the art.
Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1 , KP4 or KP6 toxins, stilbene synthases, bibenzyl synthases, chitinases, glucanases, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225), antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called "plant disease resistance genes", as described in WO 03/000906).
Further areas of use of the compositions according to the invention are the protection of stored goods and store ambients and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type.
The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors, see also http://www.who.int/malaria/vector_control/irs/en/). In one embodiment, the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping. By way of example, an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention. In another embodiment, it is contemplated to apply such compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents. A further object of the invention is therefore a substrate selected from nonwoven and fabric material comprising a composition which contains a compound of formula I.
In one embodiment, the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate. Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention. By way of example, an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface. In another embodiment, it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents. Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like. The polyesters are particularly suitable. The methods of textile treatment are known, e.g. WO 2008/151984, WO 03/034823, US 5631072, WO 2005/64072, WO 2006/128870, EP 1724392, WO 20051 13886 or WO 2007/090739.
Further areas of use of the compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees.
In the field of tree injection/trunk treatment, the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following Table:
Examples of exotic woodborers of economic importance.
Figure imgf000030_0001
Table B. Examples of native woodborers of economic importance.
Figure imgf000030_0002
Figure imgf000031_0001
Figure imgf000032_0001
The present invention may be also used to control any insect pests that may be present in turfgrass, including for example beetles, caterpillars, fire ants, ground pearls, millipedes, sow bugs, mites, mole crickets, scales, mealybugs ticks, spittlebugs, southern chinch bugs and white grubs. The present invention may be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs and adults.
In particular, the present invention may be used to control insect pests that feed on the roots of turfgrass including white grubs (such as Cyclocephala spp. (e.g. masked chafer, C. lurida), Rhizotrogus spp. (e.g. European chafer, R. majalis), Cotinus spp. (e.g. Green June beetle, C. nitida), Popillia spp. (e.g. Japanese beetle, P. japonica), Phyllophaga spp. (e.g. May/June beetle), Ataenius spp. (e.g. Black turfgrass ataenius, A. spretulus), Maladera spp. (e.g. Asiatic garden beetle, M. castanea) and Tomarus spp.), ground pearls (Margarodes spp.), mole crickets (tawny, southern, and short-winged, Scapteriscus spp., Gryllotalpa africana ) and leatherjackets (European crane fly, Tipula spp.).
The present invention may also be used to control insect pests of turfgrass that are thatch dwelling, including armyworms (such as fall armyworm Spodoptera frugiperda, and common armyworm Pseudaletia unipuncta), cutworms, billbugs ( Sphenophorus spp., such as S. venatus verstitus and S. parvulus), and sod webworms (such as Crambus spp. and the tropical sod webworm, Herpetogramma phaeopteralis).
The present invention may also be used to control insect pests ofturfgrass that live above the ground and feed on the turfgrass leaves, including chinch bugs (such as southern chinch bugs, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), rhodesgrass mealybug (Antonina graminis), two-lined spittlebug ( Propsapia bicincta), leafhoppers, cutworms ( Noctuidae family), and greenbugs.
The present invention may also be used to control other pests of turfgrass such as red imported fire ants ( Solenopsis invicta) that create ant mounds in turf.
In the hygiene sector, the compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.
Examples of such parasites are:
Of the order Anoplurida: Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp.,
Of the order Mallophagida: Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp., Of the order Diptera and the suborders Nematocerina and Brachycerina, for example Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. and Melophagus spp., Of the order Siphonapterida, for example Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp.,
Of the order Heteropterida, for example Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp.,
Of the order Blattarida, for example Blatta orientalis, Periplaneta americana, Blattelagermanica and Supella spp.,
Of the subclass Acaria (Acarida) and the orders Meta- and Meso-stigmata, for example Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp. and Varroa spp., Of the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergatesspp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp.. The compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings.
The compositions according to the invention can be used, for example, against the following pests: beetles such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus spec.,Tryptodendron spec., Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec and Dinoderus minutus, and also hymenopterans such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus and Urocerus augur, and termites such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis and Coptotermes formosanus, and bristletails such as Lepisma saccharina.
The compounds according to the invention can be used as pesticidal agents in unmodified form, but they are generally formulated into compositions in various ways using formulation adjuvants or addditives, such as carriers, solvents and surface-active substances. The formulations can be in various physical forms, e.g. in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-flowables, aqueous dispersions, oily dispersions, suspo- emulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water-miscible organic solvent as carrier), impregnated polymer films or in other forms known e.g. from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, First Edition, Second Revision (2010). Such formulations can either be used directly or diluted prior to use. The dilutions can be made, for example, with water, liquid fertilisers, micronutrients, biological organisms, oil or solvents.
The formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof.
The active ingredients can also be contained in very fine microcapsules. Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release). Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95 % by weight of the capsule weight. The active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution. The encapsulating membranes can comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art. Alternatively, very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the microcapsules are not themselves encapsulated.
The formulation adjuvants that are suitable for the preparation of the compositions according to the invention are known per se. As liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1 ,2-dichloropropane, diethanolamine, p- diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, A/,A/-dimethylformamide, dimethyl sulfoxide, 1 ,4- dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1 ,1 ,1 -trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxypropanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol, and alcohols of higher molecular weight, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, A/-methyl-2-pyrrolidone and the like.
Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances.
A large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use. Surface- active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate, salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate, alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate, alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate, soaps, such as sodium stearate, salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate, dialkyl esters of sulfosuccinate salts, such as sodium di(2- ethylhexyl)sulfosuccinate, sorbitol esters, such as sorbitol oleate, quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate, block copolymers of ethylene oxide and propylene oxide, and salts of mono- and di- alkylphosphate esters, and also further substances described e.g. in McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood New Jersey (1981).
Further adjuvants that can be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and liquid and solid fertilisers.
The compositions according to the invention can include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives. The amount of oil additive in the composition according to the invention is generally from 0.01 to 10 %, based on the mixture to be applied. For example, the oil additive can be added to a spray tank in the desired concentration after a spray mixture has been prepared. Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow. Preferred oil additives comprise alkyl esters of C8-C22 fatty acids, especially the methyl derivatives of C12-C18 fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively). Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10th Edition, Southern Illinois University, 2010.
The inventive compositions generally comprise from 0.1 to 99 % by weight, especially from 0.1 to 95 % by weight, of compounds of the present invention and from 1 to 99.9 % by weight of a formulation adjuvant which preferably includes from 0 to 25 % by weight of a surface-active substance. Whereas commercial products may preferably be formulated as concentrates, the end user will normally employ dilute formulations.
The rates of application vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. As a general guideline compounds may be applied at a rate of from 1 to 2000 l/ha, especially from 10 to 1000 l/ha.
Preferred formulations can have the following compositions (weight %):
Emulsifiable concentrates:
active ingredient: 1 to 95 %, preferably 60 to 90 %
surface-active agent: 1 to 30 %, preferably 5 to 20 %
liquid carrier: 1 to 80 %, preferably 1 to 35 %
Dusts:
active ingredient: 0.1 to 10 %, preferably 0.1 to 5 %
solid carrier: 99.9 to 90 %, preferably 99.9 to 99 % Suspension concentrates:
active ingredient: 5 to 75 %, preferably 10 to 50 %
water: 94 to 24 %, preferably 88 to 30 %
surface-active agent: 1 to 40 %, preferably 2 to 30 %
Wettable powders:
active ingredient: 0.5 to 90 %, preferably 1 to 80 %
surface-active agent: 0.5 to 20 %, preferably 1 to 15 %
solid carrier: 5 to 95 %, preferably 15 to 90 %
Granules:
active ingredient: 0.1 to 30 %, preferably 0.1 to 15 %
solid carrier: 99.5 to 70 %, preferably 97 to 85 %
The following Examples further illustrate, but do not limit, the invention
Figure imgf000037_0001
The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with waterto give suspensions of the desired concentration.
Figure imgf000037_0002
The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
Figure imgf000038_0001
Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.
Figure imgf000038_0002
Ready-for-use dusts are obtained by mixing the combination with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
Figure imgf000038_0003
The combination is mixed and ground with the adjuvants, and the mixture is moistened with water.
The mixture is extruded and then dried in a stream of air.
Figure imgf000038_0004
The finely ground combination is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
Figure imgf000039_0001
The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Figure imgf000039_0002
The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Slow Release Capsule Suspension
28 parts of the combination are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1 .2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51 .6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1 ,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
Formulation types include an emulsion concentrate (EC), a suspension concentrate (SC), a suspo- emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP), a soluble granule (SG) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.
In a further aspect, the present invention makes available a pesticidal composition comprising a compound of the first aspect, one or more formulation additives and a carrier.
The activity of the compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally, acaricidally and/orfungicidally active ingredients. The mixtures of the compounds of formula (I) with other insecticidally, acaricidally and/or fungicidally active ingredients may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages or better behaviour during their production, for example during grinding or mixing, during their storage or during their use.
Suitable additions to active ingredients here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.
The following mixtures of the compounds of formula (I) with active ingredients are preferred (the abbreviation“TX” means“one compound selected from the group consisting of a compound 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below)): an adjuvant selected from the group of substances consisting of petroleum oils (628) + TX, an acaricide selected from the group of substances consisting of 1 ,1 -bis(4-chlorophenyl)-2- ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1 -naphthylacetamide (lUPAC name) (1295) + TX, 4- chlorophenyl phenyl sulfone (lUPAC name) (981) + TX, abamectin (1) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azobenzene (lUPAC name) (888) + TX, azocyclotin (46) + TX, azothoate (889) + TX, benomyl (62) + TX, benoxafos [CCN] + TX, benzoximate (71) + TX, benzyl benzoate (lUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacryl (907) + TX, brofenvalerate + TX, bromocyclen (918) + TX, bromophos (920) + TX, bromophos-ethyl (921) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbophenothion (947) + TX, CGA 50’439 (development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971) + TX, chlorfenvinphos (131) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX, chloromethiuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel [CCN] + TX, coumaphos (174) + TX, crotamiton [CCN] + TX, crotoxyphos (1010) + TX, cufraneb (1013) + TX, cyanthoate (1020) + TX, cyflumetofen (CAS Reg. No.: 400882- 07-7) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-O (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-O (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diazinon (227) + TX, dichlofluanid (230) + TX, dichlorvos (236) + TX, dicliphos + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienochlor (1071) + TX, dimefox (1081) + TX, dimethoate (262) + TX, dinactin (653) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinobuton (269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopenton (1092) + TX, dinosulfon (1097) + TX, dinoterbon (1098) + TX, dioxathion (1 102) + TX, diphenyl sulfone (lUPAC name) (1 103) + TX, disulfiram [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapyn (1 1 13) + TX, doramectin [CCN] + TX, endosulfan (294) + TX, endothion (1 121) + TX, EPN (297) + TX, eprinomectin [CCN] + TX, ethion (309) + TX, ethoate- methyl (1 134) + TX, etoxazole (320) + TX, etrimfos (1 142) + TX, fenazaflor (1 147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, fenothiocarb (337) + TX, fenpropathrin (342) + TX, fenpyrad + TX, fenpyroximate (345) + TX, fenson (1 157) + TX, fentrifanil (1 161) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacrypyrim (360) + TX, fluazuron (1 166) + TX, flubenzimine (1 167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenoxuron (370) + TX, flumethrin (372) + TX, fluorbenside (1 174) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, gamma-HCH (430) + TX, glyodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, hexadecyl cyclopropanecarboxylate (lUPAC/Chemical Abstracts name) (1216) + TX, hexythiazox (441) + TX, iodomethane (lUPAC name) (542) + TX, isocarbophos (473) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, ivermectin [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephosfolan (1261) + TX, mesulfen [CCN] + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methidathion (529) + TX, methiocarb (530) + TX, methomyl (531 ) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime [CCN] + TX, mipafox (1293) + TX, monocrotophos (561) + TX, morphothion (1300) + TX, moxidectin [CCN] + TX, naled (567) + TX, NC-184 (compound code) + TX, NC-512 (compound code) + TX, nifluridide (1309) + TX, nikkomycins [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1 :1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, parathion (615) + TX, permethrin (626) + TX, petroleum oils (628) + TX, phenkapton (1330) + TX, phenthoate (631) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl
(652) + TX, polychloroterpenes (traditional name) (1347) + TX, polynactins (653) + TX, proclonol (1350) + TX, profenofos (662) + TX, promacyl (1354) + TX, propargite (671) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridaphenthion (701) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (71 1) + TX, quintiofos (1381) + TX, R-1492 (development code) (1382) + TX, RA-17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos + TX, selamectin [CCN] + TX, SI-0009 (compound code) + TX, sophamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI-121 (development code) (1404) + TX, sulfiram [CCN] + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfur (754) + TX, SZI-121 (development code) (757) + TX, tau-fluvalinate (398) + TX, tebufenpyrad (763) + TX, TEPP (1417) + TX, terbam + TX, tetrachlorvinphos (777) + TX, tetradifon (786) + TX, tetranactin
(653) + TX, tetrasul (1425) + TX, thiafenox + TX, thiocarboxime (1431) + TX, thiofanox (800) + TX, thiometon (801) + TX, thioquinox (1436) + TX, thuringiensin [CCN] + TX, triamiphos (1441) + TX, triarathene (1443) + TX, triazophos (820) + TX, triazuron + TX, trichlorfon (824) + TX, trifenofos (1455) + TX, trinactin (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,
an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,
an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1) + TX, doramectin [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin [CCN] + TX, ivermectin [CCN] + TX, milbemycin oxime [CCN] + TX, moxidectin [CCN] + TX, piperazine [CCN] + TX, selamectin [CCN] + TX, spinosad (737) and thiophanate (1435) + TX, an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1122) + TX, fenthion (346) + TX, pyridin-4-amine (lUPAC name) (23) and strychnine (745) + TX,
a bactericide selected from the group of substances consisting of 1 -hydroxy-1 H-pyridine-2-thione (lUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (lUPAC name) (170) + TX, copper hydroxide (lUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1105) + TX, dodicin (1112) + TX, fenaminosulf (1144) + TX, formaldehyde (404) + TX, hydrargaphen [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (lUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (61 1) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal [CCN] + TX,
a biological agent selected from the group of substances consisting of Adoxophyes orana GV (12) + TX, Agrobacterium radiobacter (13) + TX, Amblyseius spp. (19) + TX, Anagrapha falcifera NPV (28) + TX, Anagrus atomus (29) + TX, Aphelinus abdominalis (33) + TX, Aphidius colemani (34) + TX, Aphidoletes aphidimyza (35) + TX, Autographa californica NPV (38) + TX, Bacillus firmus (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51) + TX, Beauveria bassiana (53) + TX, Beauveria brongniartii (54) + TX, Chrysoperla carnea (151) + TX, Cryptolaemus montrouzieri (178) + TX, Cydia pomonella GV (191) + TX, Dacnusa sibirica (212) + TX, Diglyphus isaea (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (300) + TX, Helicoverpa zea NPV (431) + TX, Heterorhabditis bacteriophora and H. megidis (433) + TX, Hippodamia convergens (442) + TX, Leptomastix dactylopii (488) + TX, Macrolophus caliginosus (491) + TX, Mamestra brassicae NPV (494) + TX, Metaphycus helvolus (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (575) + TX, Orius spp. (596) + TX, Paecilomyces fumosoroseus (613) + TX, Phytoseiulus persimilis (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741) + TX, Steinernema bibionis (742) + TX, Steinernema carpocapsae (742) + TX, Steinernema feltiae (742) + TX, Steinernema glaseri (742) + TX, Steinernema riobrave (742) + TX, Steinernema riobravis (742) + TX, Steinernema scapterisci (742) + TX, Steinernema spp. (742) + TX, Trichogramma spp. (826) + TX, Typhlodromus occidentalis (844) and Verticillium lecanii (848) + TX,
a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,
a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir [CCN] + TX, busulfan [CCN] + TX, diflubenzuron (250) + TX, dimatif [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron [CCN] + TX, tepa [CCN] + TX, thiohempa [CCN] + TX, thiotepa [CCN] + TX, tretamine [CCN] and uredepa [CCN] + TX,
an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1 -yl acetate with (E)-dec-5-en-1 -ol (lUPAC name) (222) + TX, (E)-tridec-4-en-1 -yl acetate (lUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (lUPAC name) (541) + TX, (E,Z)-tetradeca-4,10-dien-1 -yl acetate (lUPAC name) (779) + TX, (Z)-dodec-7-en-1 -yl acetate (lUPAC name) (285) + TX, (Z)-hexadec-1 1 - enal (lUPAC name) (436) + TX, (Z)-hexadec-1 1 -en-1 -yl acetate (lUPAC name) (437) + TX, (Z)- hexadec-13-en-1 1 -yn-1 -yl acetate (lUPAC name) (438) + TX, (Z)-icos-13-en-10-one (lUPAC name) (448) + TX, (Z)-tetradec-7-en-1 -al (lUPAC name) (782) + TX, Z)-tetradec-9-en-1 -ol (lUPAC name) (783) + TX, (Z)-tetradec-9-en-1 -yl acetate (lUPAC name) (784) + TX, (7E,9Z)-dodeca-7,9-dien-1 -yl acetate (lUPAC name) (283) + TX, (9Z,1 1 E)-tetradeca-9,1 1 -dien-1 -yl acetate (lUPAC name) (780) + TX, (9Z, 12E)-tetradeca-9,12-dien-1 -yl acetate (lUPAC name) (781) + TX, 14-methyloctadec-1 -ene (lUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (lUPAC name) (544) + TX, alpha-multistriatin [CCN] + TX, brevicomin [CCN] + TX, codlelure [CCN] + TX, codlemone (167) + TX, cuelure (179) + TX, disparlure (277) + TX, dodec-8-en-1 -yl acetate (lUPAC name) (286) + TX, dodec-9-en-1 -yl acetate (lUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-1 -yl acetate (lUPAC name) (284) + TX, dominicalure [CCN] + TX, ethyl 4-methyloctanoate (lUPAC name) (317) + TX, eugenol [CCN] + TX, frontalin [CCN] + TX, gossyplure (420) + TX, grandlure (421 ) + TX, grandlure I (421) + TX, grandlure II (421) + TX, grandlure III (421) + TX, grandlure IV (421) + TX, hexalure [CCN] + TX, ipsdienol [CCN] + TX, ipsenol [CCN] + TX, japonilure (481) + TX, lineatin [CCN] + TX, litlure [CCN] + TX, looplure [CCN] + TX, medlure [CCN] + TX, megatomoic acid [CCN] + TX, methyl eugenol (540) + TX, muscalure (563) + TX, octadeca-2,13-dien-1 -yl acetate (lUPAC name) (588) + TX, octadeca-3,13-dien-1 -yl acetate (lUPAC name) (589) + TX, orfralure [CCN] + TX, oryctalure (317) + TX, ostramone [CCN] + TX, siglure [CCN] + TX, sordidin (736) + TX, sulcatol [CCN] + TX, tetradec- 1 1 -en-1 -yl acetate (lUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (839) + TX, trimedlure Bi (839) + TX, trimedlure B2 (839) + TX, trimedlure C (839) and trunc-call [CCN] + TX, an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (lUPAC name) (591) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (lUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (lUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX,
an insecticide selected from the group of substances consisting of 1 -dichloro-1 -nitroethane (lUPAC/Chemical Abstracts name) (1058) + TX, 1 ,1 -dichloro-2,2-bis(4-ethylphenyl)ethane (lUPAC name) (1056), + TX, 1 ,2-dichloropropane (lUPAC/Chemical Abstracts name) (1062) + TX, 1 ,2- dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1 -bromo-2-chloroethane (lUPAC/Chemical Abstracts name) (916) + TX, 2,2,2-trichloro-1 -(3,4-dichlorophenyl)ethyl acetate (lUPAC name) (1451) + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (lUPAC name) (1066) + TX, 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate (lUPAC/ Chemical Abstracts name) (1 109) + TX, 2-(2-butoxyethoxy)ethyl thiocyanate (lUPAC/Chemical Abstracts name) (935) + TX, 2-(4,5- dimethyl-1 ,3-dioxolan-2-yl)phenyl methylcarbamate (lUPAC/ Chemical Abstracts name) (1084) + TX, 2- (4-chloro-3,5-xylyloxy)ethanol (lUPAC name) (986) + TX, 2-chlorovinyl diethyl phosphate (lUPAC name) (984) + TX, 2-imidazolidone (lUPAC name) (1225) + TX, 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (lUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (lUPAC name) (1433) + TX, 3-bromo-1 -chloroprop-1 -ene (lUPAC name) (917) + TX, 3-methyl-1 -phenylpyrazol-5-yl dimethylcarbamate (lUPAC name) (1283) + TX, 4- methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (lUPAC name) (1285) + TX, 5,5-dimethyl-3- oxocyclohex-1 -enyl dimethylcarbamate (lUPAC name) (1085) + TX, abamectin (1) + TX, acephate (2) + TX, acetamiprid (4) + TX, acethion [CCN] + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, acrylonitrile (lUPAC name) (861) + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, allosamidin [CCN] + TX, allyxycarb (866) + TX, alpha- cypermethrin (202) + TX, alpha-ecdysone [CCN] + TX, aluminium phosphide (640) + TX, amidithion (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, anabasine (877) + TX, athidathion (883) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azadirachtin (41) + TX, azamethiphos (42) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azothoate (889) + TX, Bacillus thuringiensis delta endotoxins (52) + TX, barium hexafluorosilicate [CCN] + TX, barium polysulfide (lUPAC/Chemical Abstracts name) (892) + TX, barthrin [CCN] + TX, Bayer 22/190 (development code) (893) + TX, Bayer 22408 (development code) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta-cyfluthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S-cyclopentenyl isomer (79) + TX, bioethanomethrin [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis(2-chloroethyl) ether (lUPAC name) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate + TX, bromfenvinfos (914) + TX, bromocyclen (918) + TX, bromo-DDT [CCN] + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiofos (927) + TX, butocarboxim (103) + TX, butonate (932) + TX, butoxycarboxim (104) + TX, butylpyridaben + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide (lUPAC name) (1 1 1) + TX, camphechlor (941) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbon disulfide (lUPAC/Chemical Abstracts name) (945) + TX, carbon tetrachloride (lUPAC name) (946) + TX, carbophenothion (947) + TX, carbosulfan (1 19) + TX, cartap (123) + TX, cartap hydrochloride (123) + TX, cevadine (725) + TX, chlorbicyclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorethoxyfos (129) + TX, chlorfenapyr (130) + TX, chlorfenvinphos (131) + TX, chlorfluazuron (132) + TX, chlormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, chromafenozide (150) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, cis-resmethrin + TX, cismethrin (80) + TX, clocythrin + TX, cloethocarb (999) + TX, closantel [CCNJ + TX, clothianidin (165) + TX, copper acetoarsenite [CCN] + TX, copper arsenate [CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumithoate (1006) + TX, crotamiton [CCN] + TX, crotoxyphos (1010) + TX, crufomate (101 1) + TX, cryolite (177) + TX, CS 708 (development code) (1012) + TX, cyanofenphos (1019) + TX, cyanophos (184) + TX, cyanthoate (1020) + TX, cyclethrin [CCN] + TX, cycloprothrin (188) + TX, cyfluthrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201 ) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cythioate [CCN] + TX, cf-limonene [CCN] + TX, d-tetramethrin (788) + TX, DAEP (1031) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofuran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-O (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-O (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S- methyl (224) + TX, demeton-S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diamidafos (1044) + TX, diazinon (227) + TX, dicapthon (1050) + TX, dichlofenthion (1051) + TX, dichlorvos (236) + TX, dicliphos + TX, dicresyl [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate (lUPAC name) (1076) + TX, diflubenzuron (250) + TX, dilor [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081) + TX, dimetan (1085) + TX, dimethoate (262) + TX, dimethrin (1083) + TX, dimethylvinphos (265) + TX, dimetilan (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271 ) + TX, diofenolan (1099) + TX, dioxabenzofos (1 100) + TX, dioxacarb (1 101 ) + TX, dioxathion (1 102) + TX, disulfoton (278) + TX, dithicrofos (1 108) + TX, DNOC (282) + TX, doramectin [CCN] + TX, DSP (1 115) + TX, ecdysterone [CCN] + TX, El 1642 (development code) (1 1 18) + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, EMPC (1 120) + TX, empenthrin (292) + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, endrin (1 122) + TX, EPBP (1 123) + TX, EPN (297) + TX, epofenonane (1 124) + TX, eprinomectin [CCN] + TX, esfenvalerate (302) + TX, etaphos [CCN] + TX, ethiofencarb (308) + TX, ethion (309) + TX, ethiprole (310) + TX, ethoate-methyl (1 134) + TX, ethoprophos (312) + TX, ethyl formate (lUPAC name) [CCN] + TX, ethyl-DDD (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical name) (1 136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimfos (1 142) + TX, EXD (1 143) + TX, famphur (323) + TX, fenamiphos (326) + TX, fenazaflor (1 147) + TX, fenchlorphos (1 148) + TX, fenethacarb (1 149) + TX, fenfluthrin (1 150) + TX, fenitrothion (335) + TX, fenobucarb (336) + TX, fenoxacrim (1 153) + TX, fenoxycarb (340) + TX, fenpirithrin (1 155) + TX, fenpropathrin (342) + TX, fenpyrad + TX, fensulfothion (1 158) + TX, fenthion (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, flonicamid (358) + TX, flubendiamide (CAS. Reg. No.: 272451 -65-7) + TX, flucofuron (1 168) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1 171) + TX, flumethrin (372) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, fonofos (1 191) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, fosmethilan (1 194) + TX, fospirate (1 195) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, GY-81 (development code) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (1211) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hyquincarb (1223) + TX, imidacloprid (458) + TX, imiprothrin (460) + TX, indoxacarb (465) + TX, iodomethane (lUPAC name) (542) + TX, IPSP (1229) + TX, isazofos (1231) + TX, isobenzan (1232) + TX, isocarbophos (473) + TX, isodrin (1235) + TX, isofenphos (1236) + TX, isolane (1237) + TX, isoprocarb (472) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxathion (480) + TX, ivermectin [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, juvenile hormone I [CCN] + TX, juvenile hormone II [CCN] + TX, juvenile hormone III [CCN] + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, lepimectin (CCN) + TX, leptophos (1250) + TX, lindane (430) + TX, lirimfos (1251) + TX, lufenuron (490) + TX, lythidathion (1253) + TX, m-cumenyl methylcarbamate (lUPAC name) (1014) + TX, magnesium phosphide (lUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox (1255) + TX, mecarbam (502) + TX, mecarphon (1258) + TX, menazon (1260) + TX, mephosfolan (1261) + TX, mercurous chloride (513) + TX, mesulfenfos (1263) + TX, metaflumizone (CCN) + TX, metam (519) + TX, metam- potassium (519) + TX, metam-sodium (519) + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methanesulfonyl fluoride (lUPAC/Chemical Abstracts name) (1268) + TX, methidathion (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methothrin (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, methylchloroform [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX, metoxadiazone (1288) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime [CCNj + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561) + TX, morphothion (1300) + TX, moxidectin [CCN] + TX, naftalofos [CCN] + TX, naled (567) + TX, naphthalene (lUPAC/Chemical Abstracts name) (1303) + TX, NC-170 (development code) (1306) + TX, NC-184 (compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifluridide (1309) + TX, nitenpyram (579) + TX, nithiazine (1311) + TX, nitrilacarb (1313) + TX, nitrilacarb 1 :1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, 0-5-dichloro-4- iodophenyl O-ethyl ethylphosphonothioate (lUPAC name) (1057) + TX, 0,0-diethyl 0-4-methyl-2-oxo- 2/-/-chromen-7-yl phosphorothioate (lUPAC name) (1074) + TX, 0,0-diethyl 0-6-methyl-2- propylpyrimidin-4-yl phosphorothioate (lUPAC name) (1075) + TX, O,O,O',O'-tetrapropyl dithiopyrophosphate (lUPAC name) (1424) + TX, oleic acid (lUPAC name) (593) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydemeton-methyl (609) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, parathion (615) + TX, parathion-methyl (616) + TX, penfluron [CCN] + TX, pentachlorophenol (623) + TX, pentachlorophenyl laurate (lUPAC name) (623) + TX, permethrin (626) + TX, petroleum oils (628) + TX, PH 60-38 (development code) (1328) + TX, phenkapton (1330) + TX, phenothrin (630) + TX, phenthoate (631) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosnichlor (1339) + TX, phosphamidon (639) + TX, phosphine (lUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pirimetaphos (1344) + TX, pirimicarb (651) + TX, pirimiphos-ethyl (1345) + TX, pirimiphos-methyl (652) + TX, polychlorodicyclopentadiene isomers (lUPAC name) (1346) + TX, potassium arsenite [CCN] + TX, potassium thiocyanate [CCN] + TX, prallethrin (655) + TX, precocene I [CCN] + TX, precocene II [CCN] + TX, precocene III [CCN] + TX, primidophos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacyl (1354) + TX, promecarb (1355) + TX, propaphos (1356) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothiofos (686) + TX, prothoate (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, pyresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridaphenthion (701) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia [CCN] + TX, quinalphos (71 1) + TX, quinalphos-methyl (1376) + TX, quinothion (1380) + TX, quintiofos (1381) + TX, R-1492 (development code) (1382) + TX, rafoxanide [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (1387) + TX, ryanodine (traditional name) (1387) + TX, sabadilla (725) + TX, schradan (1389) + TX, sebufos + TX, selamectin [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129 (development code) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride (lUPAC/Chemical Abstracts name) (1399) + TX, sodium hexafluorosilicate (1400) + TX, sodium pentachlorophenoxide (623) + TX, sodium selenate (lUPAC name) (1401) + TX, sodium thiocyanate [CCN] + TX, sophamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, spiropidion (CCN) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, terallethrin (1418) + TX, terbam + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, theta-cypermethrin (204) + TX, thiacloprid (791) + TX, thiafenox + TX, thiamethoxam (792) + TX, thicrofos (1428) + TX, thiocarboxime (1431) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate (798) + TX, thiodicarb (799) + TX, thiofanox (800) + TX, thiometon (801) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin [CCN] + TX, tolfenpyrad (809) + TX, tralomethrin (812) + TX, transfluthrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron + TX, trichlorfon (824) + TX, trichlormetaphos-3 [CCN] + TX, trichloronat (1452) + TX, trifenofos (1455) + TX, triflumuron (835) + TX, trimethacarb (840) + TX, triprene (1459) + TX, vamidothion (847) + TX, vaniliprole [CCN] + TX, veratridine (725) + TX, veratrine (725) + TX, XMC (853) + TX, xylylcarb (854) + TX, YI-5302 (compound code) + TX, zeta-cypermethrin (205) + TX, zetamethrin + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (development code) (858) + TX, cyantraniliprole [736994-63-19 + TX, chlorantraniliprole [500008-45-7] + TX, cyenopyrafen [560121-52-0] + TX, cyflumetofen [400882-07-7] + TX, pyrifluquinazon [337458-27-2] + TX, spinetoram [187166-40-1 + 187166-15-0] + TX, spirotetramat [203313-25-1] + TX, sulfoxaflor [946578-00-3] + TX, flufiprole [704886-18-0] + TX, meperfluthrin [915288-13-0] + TX, tetramethylfluthrin [84937-88-2] + TX, triflumezopyrim (disclosed in WO 2012/092115) + TX,
a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimethacarb (840) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX, pyriprole [394730-71-3] + TX,
a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2-dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4-dichlorotetrahydrothiophene 1 ,1-dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4-chlorophenyl)-5-methylrhodanine (lUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3-ylacetic acid (lUPAC name) (1286) + TX, 6- isopentenylaminopurine (210) + TX, abamectin (1) + TX, acetoprole [CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben + TX, cadusafos (109) + TX, carbofuran (118) + TX, carbon disulfide (945) + TX, carbosulfan (119) + TX, chloropicrin (141) + TX, chlorpyrifos (145) + TX, cloethocarb (999) + TX, cytokinins (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, dichlofenthion (1051) + TX, dicliphos + TX, dimethoate (262) + TX, doramectin [CCN] + TX, emamectin (291) + TX, emamectin benzoate (291) + TX, eprinomectin [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad + TX, fensulfothion (1158) + TX, fosthiazate (408) + TX, fosthietan (1196) + TX, furfural [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (lUPAC name) (542) + TX, isamidofos (1230) + TX, isazofos (1231) + TX, ivermectin [CCN] + TX, kinetin (210) + TX, mecarphon (1258) + TX, metam (519) + TX, metam-potassium (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime [CCN] + TX, moxidectin [CCN] + TX, Myrothecium verrucaria composition (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos + TX, selamectin [CCN] + TX, spinosad (737) + TX, terbam + TX, terbufos (773) + TX, tetrachlorothiophene (lUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (210) + TX, fluensulfone [318290-98-1] + TX, a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,
a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutha sachalinensis extract (720) + TX, a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, alpha-chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (91) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1183) + TX, flupropadine hydrochloride (1183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (lUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (lUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, phosacetim (1336) + TX, phosphine (lUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371) + TX, scilliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851) and zinc phosphide (640) + TX,
a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (lUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (lUPAC name) (903) + TX, farnesol with nerolidol (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX,
an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (lUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,
a virucide selected from the group of substances consisting of imanin [CCN] and ribavirin [CCN] + TX,
a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX, and biologically active compounds selected from the group consisting of azaconazole (60207-31-0] + TX, bitertanol [70585-36-3] + TX, bromuconazole [116255-48-2] + TX, cyproconazole [94361-06-5] + TX, difenoconazole [119446-68-3] + TX, diniconazole [83657-24-3] + TX, epoxiconazole [106325- 08-0] + TX, fenbuconazole [1 14369-43-6] + TX, fluquinconazole [136426-54-5] + TX, flusilazole [85509-19-9] + TX, flutriafol [76674-21 -0] + TX, hexaconazole [79983-71 -4] + TX, imazalil [35554-44- 0] + TX, imibenconazole [86598-92-7] + TX, ipconazole [125225-28-7] + TX, metconazole [1251 16- 23-6] + TX, myclobutanil [88671 -89-0] + TX, pefurazoate [101903-30-4] + TX, penconazole [66246- 88-6] + TX, prothioconazole [178928-70-6] + TX, pyrifenox [88283-41 -4] + TX, prochloraz [67747-09- 5] + TX, propiconazole [60207-90-1 ] + TX, simeconazole [149508-90-7] + TX, tebuconazole [107534- 96-3] + TX, tetraconazole [1 12281 -77-3] + TX, triadimefon [43121 -43-3] + TX, triadimenol [55219-65- 3] + TX, triflumizole [99387-89-0] + TX, triticonazole [131983-72-7] + TX, ancymidol [12771 -68-5] + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71 -9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221 -53-4] + TX, ethirimol [23947-60-6] + TX, dodemorph [1593-77-7] + TX, fenpropidine [67306-00-7] + TX, fenpropimorph [67564-91 -4] + TX, spiroxamine [1 18134-30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61 -2] + TX, mepanipyrim [1 10235-47-7] + TX, pyrimethanil [531 12-28-0] + TX, fenpiclonil [74738-17-3] + TX, fludioxonil [131341 -86-1 ] + TX, benalaxyl [71626- 1 1 -4] + TX, furalaxyl [57646-30-7] + TX, metalaxyl [57837-19-1 ] + TX, R-metalaxyl [70630-17-0] + TX, ofurace [58810-48-3] + TX, oxadixyl [77732-09-3] + TX, benomyl [17804-35-2] + TX, carbendazim [10605-21 -7] + TX, debacarb [62732-91 -6] + TX, fuberidazole [3878-19-1 ] + TX, thiabendazole [148- 79-8] + TX, chlozolinate [84332-86-5] + TX, dichlozoline [24201 -58-9] + TX, iprodione [36734-19-7] + TX, myclozoline [54864-61 -8] + TX, procymidone [32809-16-8] + TX, vinclozoline [50471 -44-8] + TX, boscalid [188425-85-6] + TX, carboxin [5234-68-4] + TX, fenfuram [24691 -80-3] + TX, flutolanil [66332- 96-5] + TX, mepronil [55814-41 -0] + TX, oxycarboxin [5259-88-1 ] + TX, penthiopyrad [183675-82-3] + TX, thifluzamide [130000-40-7] + TX, guazatine [108173-90-6] + TX, dodine [2439-10-3] [1 12-65-2] (free base) + TX, iminoctadine [13516-27-3] + TX, azoxystrobin [131860-33-8] + TX, dimoxystrobin [149961 -52-4] + TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1 , 93} + TX, fluoxastrobin [361377-29-9] + TX, kresoxim-methyl [143390-89-0] + TX, metominostrobin [133408-50-1 ] + TX, trifloxystrobin [141517-21 -7] + TX, orysastrobin [248593-16-0] + TX, picoxystrobin [1 17428-22-5] + TX, pyraclostrobin [175013-18-0] + TX, ferbam [14484-64-1 ] + TX, mancozeb [8018-01 -7] + TX, maneb [12427-38-2] + TX, metiram [9006-42-2] + TX, propineb [12071 -83-9] + TX, thiram [137-26-8] + TX, zineb [12122-67-7] + TX, ziram [137-30-4] + TX, captafol [2425-06-1 ] + TX, captan [133-06-2] + TX, dichlofluanid [1085-98-9] + TX, fluoroimide [41205-21 -4] + TX, folpet [133-07-3 ] + TX, tolylfluanid [731 -27-1 ] + TX, bordeaux mixture [801 1 -63-0] + TX, copperhydroxid [20427-59-2] + TX, copperoxychlorid [1332-40-7] + TX, coppersulfat [7758-98-7] + TX, copperoxid [1317-39-1 ] + TX, mancopper [53988-93-5] + TX, oxine-copper [10380-28-6] + TX, dinocap [131 -72-6] + TX, nitrothal- isopropyl [10552-74-6] + TX, edifenphos [17109-49-8] + TX, iprobenphos [26087-47-8] + TX, isoprothiolane [50512-35-1 ] + TX, phosdiphen [36519-00-3] + TX, pyrazophos [13457-18-6] + TX, tolclofos-methyl [57018-04-9] + TX, acibenzolar-S-methyl [135158-54-2] + TX, anilazine [101 -05-3] + TX, benthiavalicarb [413615-35-7] + TX, blasticidin-S [2079-00-7] + TX, chinomethionat [2439-01 -2] + TX, chloroneb [2675-77-6] + TX, chlorothalonil [1897-45-6] + TX, cyflufenamid [180409-60-3] + TX, cymoxanil [57966-95-7] + TX, dichlone [117-80-6] + TX, diclocymet [139920-32-4] + TX, diclomezine [62865-36-5] + TX, dicloran [99-30-9] + TX, diethofencarb [87130-20-9] + TX, dimethomorph [110488- 70-5] + TX, SYP-LI90 (Flumorph) [211867-47-9] + TX, dithianon [3347-22-6] + TX, ethaboxam [162650-77-3] + TX, etridiazole [2593-15-9] + TX, famoxadone [131807-57-3] + TX, fenamidone [161326-34-7] + TX, fenoxanil [115852-48-7] + TX, fentin [668-34-8] + TX, ferimzone [89269-64- 7] + TX, fluazinam [79622-59-6] + TX, fluopicolide [2391 10-15-7] + TX, flusulfamide [106917-52-6] + TX, fenhexamid [126833-17-8] + TX, fosetyl-aluminium [39148-24-8] + TX, hymexazol [10004-44-1 ] + TX, iprovalicarb [140923-17-7] + TX, IKF-916 (Cyazofamid) [120116-88-3] + TX, kasugamycin [6980-18-3] + TX, methasulfocarb [66952-49-6] + TX, metrafenone [220899-03-6] + TX, pencycuron [66063-05-6] + TX, phthalide [27355-22-2] + TX, polyoxins [1 1 1 13-80-7] + TX, probenazole [27605-76-1 ] + TX, propamocarb [25606-41 -1 ] + TX, proquinazid [189278-12-4] + TX, pyroquilon [57369-32-1 ] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulfur [7704-34-9] + TX, tiadinil [223580- SI -6] + TX, triazoxide [72459-58-6] + TX, tricyclazole [41814-78-2] + TX, triforine [26644-46-2] + TX, validamycin [37248-47-8] + TX, zoxamide (RH7281) [156052-68-5] + TX, mandipropamid [374726-62- 2] + TX, isopyrazam [881685-58-1 ] + TX, sedaxane [874967-67-6] + TX, 3-difluoromethyl-1 -methyl-1 H- pyrazole-4-carboxylic acid (9-dichloromethylene-1 ,2,3,4-tetrahydro-1 ,4-methano-naphthalen-5-yl)- amide (dislosed in WO 2007/048556) + TX, 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide (disclosed in WO 2006/087343) + TX,
[(3S,4R,4aR,6S,6aS, 12R, 12aS, 12bS)-3-[(cyclopropylcarbonyl)oxy]- 1 ,3,4,4a,5,6,6a, 12,12a, 12b- decahydro-6,12-dihydroxy-4,6a,12b-trimethyl-1 1 -oxo-9-(3-pyridinyl)-2/-/,1 1 /-/naphtho[2,1 -b]pyrano[3,4- e]pyran-4-yl]methyl-cyclopropanecarboxylate [915972-17-7] + TX and 1 ,3,5-trimethyl-N-(2-methyl-1 - oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1 -methoxy-1 -(trifluoromethyl)ethyl]phenyl]-1 H- pyrazole-4-carboxamide [926914-55-8] + TX, lancotrione [1486617-21 -3] + TX, florpyrauxifen [943832- SI -3] ] + TX, ipfentrifluconazole[1417782-08-1 ] + TX, mefentrifluconazole [1417782-03-6] + TX, quinofumelin [861647-84-9] + TX, chloroprallethrin [399572-87-3] + TX, cyhalodiamide [1262605-53-7] ] + TX, fluazaindolizine [1254304-22-7] + TX, fluxametamide [928783-29-3] + TX, epsilon-metofluthrin [240494-71 -7] + TX, epsilon-momfluorothrin [1065124-65-3] + TX, pydiflumetofen [1228284-64-7] + TX, kappa-bifenthrin [439680-76-9] + TX, broflanilide [1207727-04-5] + TX, dicloromezotiaz [1263629-39-5] + TX, dipymetitrone [161 14-35-5] + TX, pyraziflumid [942515-63-1 ] + TX, kappa-tefluthrin [391634-71 - 2] + TX, fenpicoxamid [517875-34-2] + TX, fluindapyr [1383809-87-7] + TX, alpha-bromadiolone [28772- 56-7] + TX, flupyrimin [1689566-03-7] + TX, benzpyrimoxan [1449021 -97-9] + TX, acynonapyr [1332838-17-1 ] + TX, inpyrfluxam [1352994-67-2] + TX, isoflucypram [1255734-28-1 ] + TX, rescalure [64309-03-1 ] + TX, aminopyrifen [1531626-08-0] + TX, tyclopyrazoflor [1477919-27-9] + TX, Dichloromezotiaz + TX, Momfluorothrin + TX, Fluopyram + TX, Tioxazafen + TX, Terpenoid blend + TX, Fluhexafon + TX, Cyclaniliprole + TX, and spiropidion [1229023-00-0] + TX; and
microbials including: Acinetobacter Iwoffii + TX, Acremonium alternatum + TX + TX, Acremonium cephalosporium + TX + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, Agrobacterium radiobacter strain K84 (Galltrol-A®) + TX, Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destruens (Smolder®) + TX, Ampelomyces quisqualis (AQ10®) + TX, Aspergillus flavus AF36 (AF36®) + TX, Aspergillus flavus NRRL 21882 (Aflaguard®) + TX, Aspergillus spp. + TX, Aureobasidium pullulans + TX, Azospirillum + TX, (MicroAZ® + TX, TAZO B®) + TX, Azotobacter + TX, Azotobacter chroocuccum (Azotomeal®) + TX, Azotobacter cysts (Bionatural Blooming Blossoms®) + TX, Bacillus amyloliquefaciens + TX, Bacillus cereus + TX, Bacillus chitinosporus strain CM-1 + TX, Bacillus chitinosporus strain AQ746 + TX, Bacillus licheniformis strain HB-2 (Biostart™ Rhizoboost®) + TX, Bacillus licheniformis strain 3086 (EcoGuard® + TX, Green Releaf®) + TX, Bacillus circulans + TX, Bacillus firmus (BioSafe®, BioNem-WP®, VOTiVO®) + TX, Bacillus firmus strain 1-1582 + TX, Bacillus macerans + TX, Bacillus marismortui + TX, Bacillus megaterium + TX, Bacillus mycoides strain AQ726 + TX, Bacillus papillae (Milky Spore Powder®) + TX, Bacillus pumilus spp. + TX, Bacillus pumilus strain GB34 (Yield Shield®) + TX, Bacillus pumilus strain AQ717 + TX, Bacillus pumilus strain QST 2808 (Sonata® + TX, Ballad Plus®) + TX, Bacillus spahericus (VectoLex®) + TX, Bacillus spp. + TX, Bacillus spp. strain AQ175 + TX, Bacillus spp. strain AQ177 + TX, Bacillus spp. strain AQ178 + TX, Bacillus subtilis strain QST 713 (CEASE® + TX, Serenade® + TX, Rhapsody®) + TX, Bacillus subtilis strain QST 714 (JAZZ®) + TX, Bacillus subtilis strain AQ153 + TX, Bacillus subtilis strain AQ743 + TX, Bacillus subtilis strain QST3002 + TX, Bacillus subtilis strain QST3004 + TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 (Taegro® + TX, Rhizopro®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis Cry1 Ab + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis israelensis (BMP123® + TX, Aquabac® + TX, VectoBac®) + TX, Bacillus thuringiensis kurstaki (Javelin® + TX, Deliver® + TX, CryMax® + TX, Bonide® + TX, Scutella WP® + TX, Turilav WP ® + TX, Astuto® + TX, Dipel WP® + TX, Biobit® + TX, Foray®) + TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®) + TX, Bacillus thuringiensis kurstaki HD-1 (Bioprotec-CAF / 3P®) + TX, Bacillus thuringiensis strain BD#32 + TX, Bacillus thuringiensis strain AQ52 + TX, Bacillus thuringiensis var. aizawai (XenTari® + TX, DiPel®) + TX, bacteria spp. (GROWMEND® + TX, GROWSWEET® + TX, Shootup®) + TX, bacteriophage of Clavipacter michiganensis (AgriPhage®) + TX, Bakflor® + TX, Beauveria bassiana (Beaugenic® + TX, Brocaril WP®) + TX, Beauveria bassiana GHA (Mycotrol ES® + TX, Mycotrol O® + TX, BotaniGuard®) + TX, Beauveria brongniartii (Engerlingspilz® + TX, Schweizer Beauveria® + TX, Melocont®) + TX, Beauveria spp. + TX, Botrytis cineria + TX, Bradyrhizobium japonicum (TerraMax®) + TX, Brevibacillus brevis + TX, Bacillus thuringiensis tenebrionis (Novodor®) + TX, BtBooster + TX, Burkholderia cepacia (Deny® + TX, Intercept® + TX, Blue Circle®) + TX, Burkholderia gladii + TX, Burkholderia gladioli + TX, Burkholderia spp. + TX, Canadian thistle fungus (CBH Canadian Bioherbicide®) + TX, Candida butyri + TX, Candida famata + TX, Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, Candida oleophila strain O + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reukaufii + TX, Candida saitoana (Bio-Coat® + TX, Biocure®) + TX, Candida sake + TX, Candida spp. + TX, Candida tenius + TX, Cedecea dravisae + TX, Cellulomonas flavigena + TX, Chaetomium cochliodes (Nova-Cide®) + TX, Chaetomium globosum (Nova-Cide®) + TX, Chromobacterium subtsugae strain PRAA4-1T (Grandevo®) + TX, Cladosporium cladosporioides + TX, Cladosporium oxysporum + TX, Cladosporium chlorocephalum + TX, Cladosporium spp. + TX, Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp. + TX, Cryptococcus albidus (YIELDPLUS®) + TX, Cryptococcus humicola + TX, Cryptococcus infirmo- miniatus + TX, Cryptococcus laurentii + TX, Cryptophlebia leucotreta granulovirus (Cryptex®) + TX, Cuphavidus campinensis + TX, Cydia pomonella granulovirus (CYD-X®) + TX, Cydia pomonella granulovirus (Madex® + TX, Madex Plus® + TX, Madex Max/ Carpovirusine®) + TX, Cylindrobasidium laeve (Stumpout®) + TX, Cylindrocladium + TX, Debaryomyces hansenii + TX, Drechslera hawaiinensis + TX, Enterobacter cloacae + TX, Enterobacteriaceae + TX, Entomophtora virulenta (Vektor®) + TX, Epicoccum nigrum + TX, Epicoccum purpurascens + TX, Epicoccum spp. + TX, Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxysporum (Fusaclean® / Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop® + TX, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp. (SoilGard®) + TX, Gliocladium virens (Soilgard®) + TX, Granulovirus (Granupom®) + TX, Halobacillus halophilus + TX, Halobacillus litoralis + TX, Halobacillus trueperi + TX, Halomonas spp. + TX, Halomonas subglaciescola + TX, Halovibrio variabilis + TX, Hanseniaspora uvarum + TX, Helicoverpa armigera nucleopolyhedrovirus (Helicovex®) + TX, Helicoverpa zea nuclear polyhedrosis virus (Gemstar®) + TX, Isoflavone - formononetin (Myconate®) + TX, Kioeckera apiculata + TX, Kioeckera spp. + TX, Lagenidium giganteum (Laginex®) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertikil®) + TX, Lymantria Dispar nucleopolyhedrosis virus (Disparvirus®) + TX, Marinococcus halophilus + TX, Meira geulakonigii + TX, Metarhizium anisopliae (Met52®) + TX, Metarhizium anisopliae (Destruxin WP®) + TX, Metschnikowia fruticola (Shemer®) + TX, Metschnikowia pulcherrima + TX, Microdochium dimerum (Antibot®) + TX, Micromonospora coerulea + TX, Microsphaeropsis ochracea + TX, Muscodor albus 620 (Muscudor®) + TX, Muscodor roseus strain A3-5 + TX, Mycorrhizae spp. (AMykor® + TX, Root Maximizer®) + TX, Myrothecium verrucaria strain AARC-0255 (DiTera®) + TX, BROS PLUS® + TX, Ophiostoma piliferum strain D97 (Sylvanex®) + TX, Paecilomyces farinosus + TX, Paecilomyces fumosoroseus (PFR-97® + TX, PreFeRal®) + TX, Paecilomyces linacinus (Biostat WP®) + TX, Paecilomyces lilacinus strain 251 (MeloCon WG®) + TX, Paenibacillus polymyxa + TX, Pantoea agglomerans (BlightBan C9-1 ®) + TX, Pantoea spp. + TX, Pasteuria spp. (Econem®) + TX, Pasteuria nishizawae + TX, Penicillium aurantiogriseum + TX, Penicillium billai (Jumpstart® + TX, TagTeam®) + TX, Penicillium brevicompactum + TX, Penicillium frequentans + TX, Penicillium griseofulvum + TX, Penicillium purpurogenum + TX, Penicillium spp. + TX, Penicillium viridicatum + TX, Phlebiopsis gigantean (Rotstop®) + TX, phosphate solubilizing bacteria (Phosphomeal®) + TX, Phytophthora cryptogea + TX, Phytophthora palmivora (Devine®) + TX, Pichia anomala + TX, Pichia guilermondii + TX, Pichia membranaefaciens + TX, Pichia onychis + TX, Pichia stipites + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX, Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida + TX, Pseudomonas reactans + TX, Pseudomonas spp. + TX, Pseudomonas syringae (Bio-Save®) + TX, Pseudomonas viridiflava + TX, Pseudomons fluorescens (Zequanox®) + TX, Pseudozyma fioccuiosa strain PF-A22 UL (Sporodex L®) + TX, Puccinia canaliculate + TX, Puccinia thlaspeos (Wood Warrior®) + TX, Pythium paroecandrum + TX, Pythium oligandrum (Polygandron® + TX, Polyversum®) + TX, Pythium periplocum + TX, Rhanella aquatilis + TX, Rhanella spp. + TX, Rhizobia (Dormal® + TX, Vault®) + TX, Rhizoctonia + TX, Rhodococcus globerulus strain AQ719 + TX, Rhodosporidium diobovatum + TX, Rhodosporidium toruloides + TX, Rhodotorula spp. + TX, Rhodotorula glutinis + TX, Rhodotorula graminis + TX, Rhodotorula mucilagnosa + TX, Rhodotorula rubra + TX, Saccharomyces cerevisiae + TX, Salinococcus roseus + TX, Sclerotinia minor + TX, Sclerotinia minor (SARRITOR®) + TX, Scytalidium spp. + TX, Scytalidium uredinicola + TX, Spodoptera exigua nuclear polyhedrosis virus (Spod-X® + TX, Spexit®) + TX, Serratia marcescens + TX, Serratia plymuthica + TX, Serratia spp. + TX, Sordaria fimicola + TX, Spodoptera littoralis nucleopolyhedrovirus (Littovir®) + TX, Sporobolomyces roseus + TX, Stenotrophomonas maltophilia + TX, Streptomyces ahygroscopicus + TX, Streptomyces albaduncus + TX, Streptomyces exfoliates + TX, Streptomyces galbus + TX, Streptomyces griseoplanus + TX, Streptomyces griseoviridis (Mycostop®) + TX, Streptomyces lydicus (Actinovate®) + TX, Streptomyces lydicus WYEC-108 (ActinoGrow®) + TX, Streptomyces violaceus + TX, Tilletiopsis minor + TX, Tilletiopsis spp. + TX, Trichoderma asperellum (T34 Biocontrol®) + TX, Trichoderma gamsii (Tenet®) + TX, Trichoderma atroviride (Plantmate®) + TX, Trichoderma hamatum TH 382 + TX, Trichoderma harzianum rifai (Mycostar®) + TX, Trichoderma harzianum T-22 (Trianum-P® + TX, PlantShield HC® + TX, RootShield® + TX, Trianum-G®) + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma spp. LC 52 (Sentinel®) + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma taxi + TX, Trichoderma virens + TX, Trichoderma virens (formerly Gliocladium virens GL-21) (SoilGuard®) + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX, Trichothecium spp. + TX, Trichothecium roseum + TX, Typhula phacorrhiza strain 94670 + TX, Typhula phacorrhiza strain 94671 + TX, Ulocladium atrum + TX, Ulocladium oudemansii (Botry-Zen®) + TX, Ustilago maydis + TX, various bacteria and supplementary micronutrients (Natural II®) + TX, various fungi (Millennium Microbes®) + TX, Verticillium chlamydosporium + TX, Verticillium lecanii (Mycotal® + TX, Vertalec®) + TX, Vip3Aa20 (VIPtera®) + TX, Virgibaclillus marismortui + TX, Xanthomonas campestris pv. Poae (Camperico®) + TX, Xenorhabdus bovienii + TX, Xenorhabdus nematophilus, and
Plant extracts including: pine oil (Retenol®) + TX, azadirachtin (Plasma Neem Oil® + TX, AzaGuard® + TX, MeemAzal® + TX, Molt-X® + TX, Botanical IGR (Neemazad®, Neemix®) + TX, canola oil (Lilly Miller Vegol®) + TX, Chenopodium ambrosioides near ambrosioides (Requiem®) + TX, Chrysanthemum extract (Crisant®) + TX, extract of neem oil (Trilogy®) + TX, essentials oils of Labiatae (Botania®) + TX, extracts of clove rosemary peppermint and thyme oil (Garden insect killer®) + TX, Glycinebetaine (Greenstim®) + TX, garlic + TX, lemongrass oil (GreenMatch®) + TX, neem oil + TX, Nepeta cataria (Catnip oil) + TX, Nepeta catarina + TX, nicotine + TX, oregano oil (MossBuster®) + TX, Pedaliaceae oil (Nematon®) + TX, pyrethrum + TX, Quillaja saponaria (NemaQ®) + TX, Reynoutria sachalinensis (Regalia® + TX, Sakalia®) + TX, rotenone (Eco Roten®) + TX, Rutaceae plant extract (Soleo®) + TX, soybean oil (Ortho ecosense®) + TX, tea tree oil (Timorex Gold®) + TX, thymus oil + TX, AGNIQUE® MMF + TX, BugOil® + TX, mixture of rosemary sesame pepermint thyme and cinnamon extracts (EF 300®) + TX, mixture of clove rosemary and peppermint extract (EF 400®) + TX, mixture of clove pepermint garlic oil and mint (Soil Shot®) + TX, kaolin (Screen®) + TX, storage glucam of brown algae (Laminarin®) + TX, and
pheromones including: blackheaded fireworm pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Codling Moth Pheromone (Paramount dispenser-(CM)/ Isomate C-Plus®) + TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone®) + TX, Leafroller pheromone (3M MEC - LR Sprayable Pheromone®) + TX, Muscamone (Snip7 Fly Bait® + TX, Starbar Premium Fly Bait®) + TX, Oriental Fruit Moth Pheromone (3M oriental fruit moth sprayable pheromone®) + TX, Peachtree Borer Pheromone (Isomate-P®) + TX, Tomato Pinworm Pheromone (3M Sprayable pheromone®) + TX, Entostat powder (extract from palm tree) (Exosex CM®) + TX, Tetradecatrienyl acetate + TX, 13-Hexadecatrienal + TX, (E + TX,Z)-7 + TX,9-Dodecadien-1 -yl acetate + TX, 2-Methyl- 1 -butanol + TX, Calcium acetate + TX, Scenturion® + TX, Biolure® + TX, Check-Mate® + TX, Lavandulyl senecioate, and
Macrobials including: Aphelinus abdominalis + TX, Aphidius ervi (Aphelinus-System®) + TX, Acerophagus papaya + TX, Adalia bipunctata (Adalia-System®) + TX, Adalia bipunctata (Adaline®) + TX, Adalia bipunctata (Aphidalia®) + TX, Ageniaspis citricola + TX, Ageniaspis fuscicollis + TX, Amblyseius andersoni (Anderline® + TX, Andersoni-System®) + TX, Amblyseius californicus (Amblyline® + TX, Spical®) + TX, Amblyseius cucumeris (Thripex® + TX, Bugline cucumeris®) + TX, Amblyseius fallacis (Fallacis®) + TX, Amblyseius swirskii (Bugline swirskii® + TX, Swirskii-Mite®) + TX, Amblyseius womersleyi (WomerMite®) + TX, Amitus hesperidum + TX, Anagrus atomus + TX, Anagyrus fusciventris + TX, Anagyrus kamali + TX, Anagyrus loecki + TX, Anagyrus pseudococci (Citripar®) + TX, Anicetus benefices + TX, Anisopteromalus calandrae + TX, Anthocoris nemoralis (Anthocoris- System®) + TX, Aphelinus abdominalis (Apheline® + TX, Aphiline®) + TX, Aphelinus asychis + TX, Aphidius colemani (Aphipar®) + TX, Aphidius ervi (Ervipar®) + TX, Aphidius gifuensis + TX, Aphidius matricariae (Aphipar-M®) + TX, Aphidoletes aphidimyza (Aphidend®) + TX, Aphidoletes aphidimyza (Aphidoline®) + TX, Aphytis lingnanensis + TX, Aphytis melinus + TX, Aprostocetus hagenowii + TX, Atheta coriaria (Staphyline®) + TX, Bombus spp. + TX, Bombus terrestris (Natupol Beehive®) + TX, Bombus terrestris (Beeline® + TX, T ripol®) + TX, Cephalonomia stephanoderis + TX, Chilocorus nigritus + TX, Chrysoperla carnea (Chrysoline®) + TX, Chrysoperla carnea (Chrysopa®) + TX, Chrysoperla rufUabris + TX, Cirrospilus ingenuus + TX, Cirrospilus quadristriatus + TX, Citrostichus phyllocnistoides + TX, Closterocerus chamaeleon + TX, Closterocerus spp. + TX, Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cryptolaemus montrouzieri (Cryptobug® + TX, Cryptoline®) + TX, Cybocephalus nipponicus + TX, Dacnusa sibirica + TX, Dacnusa sibirica (Minusa®) + TX, Diglyphus isaea (Diminex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaphorencyrtus aligarhensis + TX, Diglyphus isaea + TX, Diglyphus isaea (Miglyphus® + TX, Digline®) + TX, Dacnusa sibirica (DacDigline® + TX, Minex®) + TX, Diversinervus spp. + TX, Encarsia citrina + TX, Encarsia formosa (Encarsia max® + TX, Encarline® + TX, En-Strip®) + TX, Eretmocerus eremicus (Enermix®) + TX, Encarsia guadeloupae + TX, Encarsia haitiensis + TX, Episyrphus balteatus (Syrphidend®) + TX, Eretmocehs siphonini + TX, Eretmocerus californicus + TX, Eretmocerus eremicus (Ercal® + TX, Eretline e®) + TX, Eretmocerus eremicus (Bemimix®) + TX, Eretmocerus hayati + TX, Eretmocerus mundus (Bemipar® + TX, Eretline m®) + TX, Eretmocerus siphonini + TX, Exochomus quadripustulatus + TX, Feltiella acarisuga (Spidend®) + TX, Feltiella acarisuga (Feltiline®) + TX, Fopius arisanus + TX, Fopius ceratitivorus + TX, Formononetin (Wirless Beehome®) + TX, Franklinothrips vespiformis (Vespop®) + TX, Galendromus occidentalis + TX, Goniozus legneri + TX, Flabrobracon hebetor + TX, Harmonia axyridis (HarmoBeetle®) + TX, Heterorhabditis spp. (Lawn Patrol®) + TX, Heterorhabditis bacteriophora (NemaShield HB® + TX, Nemaseek® + TX, Terranem-Nam® + TX, Terranem® + TX, Larvanem® + TX, B-Green® + TX, NemAttack ® + TX, Nematop®) + TX, Heterorhabditis megidis (Nemasys H® + TX, BioNem H® + TX, Exhibitline hm® + TX, Larvanem-M®) + TX, Hippodamia convergens + TX, Hypoaspis aculeifer (Aculeifer-System® + TX, Entomite-A®) + TX, Hypoaspis miles (Hypoline m® + TX, Entomite-M®) + TX, Lbalia leucospoides + TX, Lecanoideus floccissimus + TX, Lemophagus errabundus + TX, Leptomastidea abnormis + TX, Leptomastix dactylopii (Leptopar®) + TX, Leptomastix epona + TX, Lindorus lophanthae + TX, Lipolexis oregmae + TX, Lucilia caesar (Natufly®) + TX, Lysiphlebus testaceipes + TX, Macrolophus caliginosus (Mirical-N® + TX, Macroline c® + TX, Mirical®) + TX, Mesoseiulus longipes + TX, Metaphycus fiavus + TX, Metaphycus lounsburyi + TX, Micromus angulatus (Milacewing®) + TX, Microterys fiavus + TX, Muscidifurax raptorellus and Spalangia cameroni (Biopar®) + TX, Neodryinus typhlocybae + TX, Neoseiulus californicus + TX, Neoseiulus cucumeris (THRYPEX®) + TX, Neoseiulus fallacis + TX, Nesideocoris tenuis (NesidioBug® + TX, Nesibug®) + TX, Ophyra aenescens (Biofly®) + TX, Orius insidiosus (Thripor-I® + TX, Oriline i®) + TX, Orius laevigatus (Thripor-L® + TX, Oriline I®) + TX, Orius majusculus (Oriline m®) + TX, Orius strigicollis (Thripor-S®) + TX, Pauesia juniperorum + TX, Pediobius foveolatus + TX, Phasmarhabditis hermaphrodita (Nemaslug®) + TX, Phymastichus coffea + TX, Phytoseiulus macropilus + TX, Phytoseiulus persimilis (Spidex® + TX, Phytoline p®) + TX, Podisus maculiventris (Podisus®) + TX, Pseudacteon curvatus + TX, Pseudacteon obtusus + TX, Pseudacteon tricuspis + TX, Pseudaphycus maculipennis + TX, Pseudleptomastix mexicana + TX, Psyllaephagus pilosus + TX, Psyttalia concolor (complex) + TX, Quadrastichus spp. + TX, Rhyzobius lophanthae + TX, Rodolia cardinalis + TX, Rumina decollate + TX, Semielacher petiolatus + TX, Sitobion avenae (Ervibank®) + TX, Steinernema carpocapsae (Nematac C® + TX, Millenium® + TX, BioNem C® + TX, NemAttack® + TX, Nemastar® + TX, Capsanem®) + TX, Steinernema feltiae (NemaShield® + TX, Nemasys F® + TX, BioNem F® + TX, Steinernema-System® + TX, NemAttack® + TX, Nemaplus® + TX, Exhibitline sf® + TX, Scia-rid® + TX, Entonem®) + TX, Steinernema kraussei (Nemasys L® + TX, BioNem L® + TX, Exhibitline srb®) + TX, Steinernema riobrave (BioVector® + TX, BioVektor®) + TX, Steinernema scapterisci (Nematac S®) + TX, Steinernema spp. + TX, Steinernematid spp. (Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator, and other biologicals including: abscisic acid + TX, bioSea® + TX, Chondrostereum purpureum (Chontrol Paste®) + TX, Colletotrichum gloeosporioides (Collego®) + TX, Copper Octanoate (Cueva®) + TX, Delta traps (Trapline d®) + TX, Erwinia amylovora (Harpin) (ProAct® + TX, Ni-HIBIT Gold CST®) + TX, Ferri-phosphate (Ferramol®) + TX, Funnel traps (Trapline y®) + TX, Gallex® + TX, Grower's Secret® + TX, Homo-brassonolide + TX, Iron Phosphate (Lilly Miller Worry Free Ferramol Slug & Snail Bait®) + TX, MCP hail trap (Trapline f®) + TX, Microctonus hyperodae + TX, Mycoleptodiscus terrestris (Des- X®) + TX, BioGain® + TX, Aminomite® + TX, Zenox® + TX, Pheromone trap (Thripline ams®) + TX, potassium bicarbonate (MilStop®) + TX, potassium salts of fatty acids (Sanova®) + TX, potassium silicate solution (Sil-Matrix®) + TX, potassium iodide + potassiumthiocyanate (Enzicur®) + TX, SuffOil- X® + TX, Spider venom + TX, Nosema locustae (Semaspore Organic Grasshopper Control®) + TX, Sticky traps (Trapline YF® + TX, Rebell Amarillo®) + TX and Traps (Takitrapline y + b®) + TX.
The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium, Thirteenth Edition, Editor: C. D. S. TomLin, The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound, for example, the compound "abamectin" is described under entry number (1). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood, Compendium of Pesticide Common Names. Copyright © 1995-2004], for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html.
Most of the active ingredients described above are referred to hereinabove by a so-called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound, in that case, the lUPAC name, the lUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "development code" is used. “CAS Reg. No” means the Chemical Abstracts Registry Number.
The ratio (by weight) of active ingredient mixture of the compounds of formula (I) selected from a compound 1.001 to 1.140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below) with active ingredients described above is from 100:1 to 1 :6000, especially from 50:1 to 1 :50, more especially in a ratio of from 20:1 to 1 :20, even more especially from 10:1 to 1 :10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1 :1 , or 5:1 , or 5:2, or 5:3, or 5:4, or 4:1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2:1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 :150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750.
The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
The mixtures comprising a compound of formula (I) selected from a compound 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below) and one or more active ingredients as described above can be applied, for example, in a single“ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one afterthe other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula (I) selected from a compound 1 .001 to 1 .140 listed in Table 1 (below) or a compound A1 to A42 listed in Table A (below) and the active ingredients as described above is not essential for working the present invention.
In a further aspect, the present invention provides a combination of active ingredients comprising a compound defined in the first aspect, and one or more further active ingredients (whether chemical or biological).
The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds (I) for the preparation of these compositions are also a subject of the invention.
The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha.
A preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question. Alternatively, the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field. The compounds of the invention and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type. The propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing. Alternatively, the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling. These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention. Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds.
The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.
The present invention also comprises seeds coated or treated with or containing a compound of formula (I). The term "coated or treated with and/or containing" generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application. When the said seed product is (re)planted, it may absorb the active ingredient. In an embodiment, the present invention makes available a plant propagation material adhered thereto with a compound of formula (I). Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound of formula (I).
Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. The seed treatment application of the compound formula (I) can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the sowing/planting of the seeds.
A further aspect is a plant propagation material comprising by way of treatment or coating one or more compounds of formula (I) according to the invention, optionally also comprising a colour pigment.
In each aspect and embodiment of the invention, "consisting essentially" and inflections thereof are a preferred embodiment of "comprising" and its inflections, and "consisting of" and inflections thereof are a preferred embodiment of "consisting essentially of and its inflections.
The disclosure in the present application makes available each and every combination of embodiments disclosed herein.
Table 1 : This table discloses the 140 compounds of the formula (1-1): (1-1) wherein m is 0, R3a and R3b are hydrogen, and R1 and R4 are as defined in the below Table.
Figure imgf000061_0001
Figure imgf000062_0001
Figure imgf000063_0001
Figure imgf000064_0001
Figure imgf000065_0001
Figure imgf000066_0001
Figure imgf000067_0001
Figure imgf000068_0001
Figure imgf000069_0001
Figure imgf000070_0001
Figure imgf000071_0001
Figure imgf000072_0001
EXAMPLES The Examples which follow serve to illustrate the invention.
The compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm or 0.2 ppm, or lower application rates, such as 300, 200 or 100 mg of Al per m2.
Compounds of Formula (I) may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against insects or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile (including improved crop tolerance), improved physico- chemical properties, or increased biodegradability). Throughout this description, temperatures are given in degrees Celsius (°C) and“mp.” means melting point.
LC/MS means Liquid Chromatography Mass Spectrometry and the description of the apparatus and the method A is outlined below. The characteristic LC/MS values obtained for each compound were the retention time (“Rt”, recorded in minutes (min)) and the measured molecular ion (M+H)+ and/or (M- H)-.
1 H NMR measurements were recorded on Brucker 400 MHz or 300 MHz spectrometers, chemical shifts are given in ppm relevant to a TMS standard. Spectra are measured in deuterated solvents (eg, dimethyl sulfoxide (DMSO)) as indicated.
LCMS Methods:
Method A: Standard
Spectra were recorded on a Mass Spectrometer from Waters (SQD, SQDII Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive and negative ions, Capillary: 3.00 kV, Cone range: 30 V, Extractor: 2.00 V, Source Temperature: 150°C, Desolvation Temperature: 350°C, Cone Gas Flow: 50 l/h, Desolvation Gas Flow: 650 l/h, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment, diode-array detector and ELSD detector. Column: Waters UPLC HSS T3, 1 .8 mhi, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH, gradient: 10-100% B in 1 .2 min; Flow (ml/min) 0.85.
Method B: HSS QC method
Spectra were recorded on a ACQUITY Mass Spectrometer from Waters Corporations (SQD or SQDII Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.0 kV, Cone: 30V, Extractor: 3.00 V, Source Temperature: 150°C, Desolvation Temperature: 400°C, Cone Gas Flow: 60 L/hr, Desolvation Gas Flow: 700 L/hr, Mass range: 140 to 800 Da) and an ACQUITY UPLC from Waters Corporations with solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1 .8 pm, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 400, Solvent Gradient: A = Water/Methanol 9:1 + 0.1 % formic acid, B= Acetonitrile + 0.1 % formic acid, gradient: 0-100% B in 2.5 min; Flow (ml/min) 0.75.
Example P1 : Preparation of 4-[(6-chloro-3-pyridyl) methyl]-1 -(2,2-difluoroethyl)imidazo[4,5-b]pyridin-2- one (compound A11).
Figure imgf000074_0001
To a solution of 2,3-diaminopyridine (10 g, 87.1 mmol, CAS = [452-58-4]) in pyridine (348 ml_) was added sulfamide (12.7 g, 130.6 mmol) and the mixture was refluxed for 1.5 hour. After cooling, pyridine was removed under reduced pressure and residual pyridine was removed by azeotrope evaporation using toluene to give a crude black solid. Purification by chromatography on silica gel (dichloromethane/methanol gradient, 95:5 90:10) afforded 1 ,3-dihydro-[1 ,2,5]thiadiazolo[3,4- b] pyridine 2,2-dioxide (8.6 g, 58%) as a yellow solid.
Ή-NMR (400 MHz, DMSO-de): d = 7.17 (dd, J = 1.2, 6.6 Hz, 1 H), 6.77 (dd, J = 1.2, 7.2 Hz, 1 H),
6.49-6.42 (m, 1 H); LCMS (method A): Rt = 0.16, m/z = 172 (M+H+).
Step B: Preparation of 1-methyl-3H-[1 ,2,5]thiadiazolo[3,4-b] pyridine 2,2-dioxide.
Figure imgf000074_0002
To a solution of 1 ,3-dihydro-[1 ,2,5]thiadiazolo[3,4-b] pyridine 2,2-dioxide (8.6 g, 50.2 mmol) in
DMF (167 ml_) was added 60% NaH (2.2 g, 55.26 mmol). The suspension was stirred at room temperature for one hour, and a solution of B0C2O (12.2 g, 55.26 mmol) in DMF (40ml_) added dropwise. The reaction mixture was then stirred overnight and concentrated. The residue was diluted with ethyl acetate (50 ml_) and a saturated aqueous solution of ammonium chloride (50 ml_). The aqueous phase was extracted with ethyl acetate (10 ml_) and the combined organic phases washed with water (2 x 10 ml_), brine (10 ml_), dried with sodium sulfate, filtered and evaporated to give a crude black residue. Purification by chromatography on silica gel (cyclohexane/ethyl acetate gradient, 1 :1 0:1) afforded 1- methyl-3H-[1 ,2,5]thiadiazolo[3,4-b] pyridine 2,2-dioxide as a yellow/green foam (9.9 g, 73%). Ή-NMR (400 MHz, DMSO-de): 5 7.59 (dd, J = 1 .2, 7.4 Hz, 1 H), 7.48 (dd, J = 1 .2, 6.6 Hz, 1 H), 6.68 (dd, J = 6.6, 7.4 Hz, 1 H), 1 .54 (s, 9H); LCMS (method A): Rt = 0.75, m/z = 272 (M+H+).
Step C: Preparation of tert-butyl 4-[(6-chloro-3-pyridyl)methyl]-2,2-dioxo-[1 ,2,5]thiadiazolo[3,4- b] pyridine-1 -carboxylate.
Figure imgf000075_0001
To a solution of 1 -methyl-3H-[1 ,2,5]thiadiazolo[3,4-b] pyridine 2,2-dioxide ( 9.1 g, 33.6 mmol) in DMF (134 mL) was added potassium carbonate (13.9 g, 100.7 mmol) and 2-chloro-5- (chloromethyl)pyridine (B, 10.88 g, 67.16 mmol). The resulting mixture was stirred at room temperature overnight and quenched with water (100 mL). The aqueous phase is extracted with ethyl acetate (2 c 30 mL), the combined organic phases were washed with water (2x 10 mL), brine (10 mL), and dried with sodium sulfate, filtered and evaporated. Purification by chromatography on silica gel (cyclohexane/ethyl acetate gradient, 1 :1— >0:1) afforded tert-butyl 4-[(6-chloro-3-pyridyl)methyl]-2,2- dioxo-[1 , 2, 5]thiadiazolo[3,4-b] pyridine-1 -carboxylate (1 1 .48 g, 86%) as a light yellow solid.
1H-NMR (400 MHz, DMSO-de): <5 = 8.50 (d, J = 2.6 Hz, 1 H), 7.88-7.83 (m, 2H), 7.62-7.55 (m, 2H), 6.79 (s, 1 H), 5.40 (s, 2H), 1 .54 (s, 9H); LCMS (method A): Rt 0.94, m/z = 397 (M+H+).
Step D: Preparation of 4-[(6-chloro-3-pyridyl)methyl]-1 H-[1 ,2,5]thiadiazolo[3,4-b] pyridine 2,2-dioxide.
Figure imgf000075_0002
A three necked 200 ml_ flask fitted with a condenser is charged with tert-butyl 4-[(6-chloro-3- pyridyl)methyl]-2,2-dioxo-[1 ,2,5]thiadiazolo[3,4-b]pyridine-1 -carboxylate (13.7g, 33.1 mmol) in MeOH (300 ml_). Acetyl chloride (7.17 ml_, 99.4 mmol) is added dropwise and carefully (gas evolution during the addition) and the resulting yellow suspension is stirred at 65°C for four hours. The reaction mixture is evaporated to give 4-[(6-chloro-3-pyridyl)methyl]-1 H-[1 ,2,5]thiadiazolo[3,4-b]pyridine 2,2-dioxide (10.7 g, 100%) as a beige solid, which was used in the next step without any further purification.
1H-NMR (400 MHz, DMSO-de): <5 = 1 1 .29 (br s, 1 H), 8.50 (d, J = 2.3 Hz, 1 H), 7.86 (dd, J = 2.3, 8.5 Hz, 1 H), 7.57 (dd, J = 1 .1 , 7.1 Hz, 1 H), 7.56 (d, J = 8.5 Hz, 1 H), 6.77 (dd, J = 1 .1 , 7.1 Hz, 1 H), 6.55 (t, J = 7.1 Hz, 1 H), 5.35 (s, 2H); LCMS (method A): Rt = 0.57, m/z = 297 (M+1). Step E: Preparation of 1 -[(6-chloro-3-pyridyl)methyl]-2-imino-pyridin-3-amine.
Figure imgf000076_0002
A 25 mL microwave vial was charged with 4-[(6-chloro-3-pyridyl)methyl]-1 H- [1 ,2,5]thiadiazolo[3,4-b] pyridine 2,2-dioxide (1 g, 2.36 mmol) and aqueous 37% HCI (6 mL). The vial was sealed and the purple mixture stirred at 1 10°C for 30 minutes. The reaction was cooled at 40°C and the overpressure in the vial released carefully. The vial was sealed again and the orange mixture further stirred at 1 10°C for two hours. The reaction mixture was cooled at room temperature, poured on ice, and basified to pH 10 with aqueous 10M NaOH (8 mL). The aqueous phase was extracted with dichloromethane (4 c 30 mL), and the combined organic phases washed with water (5 mL), brine (5 mL), dried with sodium sulfate, filtered and evaporated to give 1 -[(6-chloro-3-pyridyl)methyl]-2-imino- pyridin-3-amine (270 mg, 49%) as an orange gum.
Ή-NMR (400 MHz, DMSO-de): d = 8.37 (d, J = 2.3 Hz, 1 H), 7.74 (dd, J = 2.3, 8.4 Hz, 1 H), 7.47 (d, J = 8.4 Hz, 1 H), 6.86 (dd, J = 1 .5, 7.0 Hz, 1 H), 6.05 (dd, J = 1 .5, 7.0 Hz, 1 H), 5.67 (t, J = 7.0 Hz, 1 H), 5.15-5.05 (m, 4H); LCMS (method A): Rt = 0.25, m/z = 235 (M+H+).
Step F: Preparation of 4-[(6-chloro-3-pyridyl)methyl]-1 H-imidazo[4,5-b]pyridin-2-one.
Figure imgf000076_0001
To a solution of 1 -[(6-chloro-3-pyridyl)methyl]-2-imino-pyridin-3-amine (715 mg, 2.59 mmol) in dichloromethane (30 mL) cooled at 0°C was added phosgene (15% in toluene, 2.59 mL, 3.63 mmol) and the reaction mixture stirred at room temperature overnight. The reaction was then cooled at 5°C, quenched with a 7M solution of ammonia in MeOH (2 mL) and evaporated. Purification by chromatography on silica gel (dichloromethane/methanol, 90:10®80:20) afford 4-[(6-chloro-3- pyridyl)methyl]-1 H-imidazo[4,5-b]pyridin-2-one (600 mg, 90%).
1H-NMR (400 MHz, DMSO-de): 5 10.66 (bs, 1 H), 8.54 (d, J = 2.3 Hz, 1 H), 7.89 (dd, J = 2.3, 8.4 Hz, 1 H), 7.73 (dd, J = 1 .0, 7.2 Hz, 1 H), 7.53 (d, J = 8.4 Hz, 1 H), 6.97 (dd, J = 1 .0, 7.2 Hz, 1 H), 6.69 (t, J = 7.2 Hz, 1 H), 5.49 (s, 2H); LCMS (method A): Rt 0.30, m/z = 261 (M+H+).
Alternative step F: Preparation of 4-[(6-chloro-3-pyridyl)methyl]-1 H-imidazo[4,5-b]pyridin-2-one. A flask was charged with 1 -[(6-chloro-3-pyridyl) methyl]-2-imino-pyridin-3-amine (HCI salt, 1 1 4g, 78% purity) and heated to 150°C to give a dark brown viscous solution. Urea (4.50, 9.01 g, 4.5 equiv.) was then added solid in one portion. The resulting brown suspension was stirred for 15 hrs at 150°C. The mixture was diluted with EtOH and the solvent was evaporated under vacuum. Purification by chromatography on silica gel (dichloromethane/methanol gradient) afforded a sticky solid. The solid obtained was triturated in a mixture out of MeOH and f-butyl methyl ester to give, after filtration, the title compound (78% yield). LCMS (method A): Rt = 0.28, /z = 261 (M+H+). The same reaction could be undertaken using 1 -[(6-chloro-3-pyridyl) methyl]-2-imino-pyridin-3-amine (salt-free). LCMS (method A): Rt = 0.28, m/z = 261 (M+H+).
Step G: Preparation of 4-[(6-chloro-3-pyridyl)methyl]-1 -(2,2-difluoroethyl)imidazo[4,5-b]pyridin-2-one (compound A11).
A 5 mL flask, under argon, was charged with 4-[(6-chloro-3-pyridyl)methyl]-1 H-imidazo[4,5- b]pyridin-2-one (200 mg, 0.38 mmol), DMF (2 mL), NaH (17 mg, 0.422 mmol) and the reaction mixture was stirred at room temperature for 15 minutes. 2,2-difluoroethyl trifluoromethanesulfonate (101 mg, 0.46 mmol) was then added and the dark brown-red mixture was stirred for two hours and was carefully quenched with MeOH (1 mL) and poured onto ice. The aqueous phase was extracted with ethyl acetate (3 x 2 mL), the combined organic phases washed with water (2 mL), brine (2 mL), dried with sodium sulfate, filtered and evaporated to give a yellow gum. Purification by chromatography on silica gel (dichloromethane/methanol gradient, 100: 0®90:10) afforded 4-[(6-chloro-3-pyridyl)methyl]-1 -(2,2- difluoroethyl)imidazo[4,5-b]pyridin-2-one as a white solid (40 mg, 32%).
1H-NMR (400 MHz, CD3OD): 5 = 8.50 (d, J = 2.6 Hz, 1 H), 7.90 (dd, J = 2.6, 7.9 Hz, 1 H), 7.81 (dd, J = 0.7, 6.6 Hz, 1 H), 7.45 (d, J = 7.9 Hz, 1 H), 7.39 (dd, J = 0.7, 7.2 Hz, 1 H), 6.95 (t, J = 7.2 Hz, 1 H), 6.30-5.98 (m, 1 H), 5.61 (s, 2H); LCMS (method A): Rt = 0.64, m/z = 325 (M+H+).
Example P2: Preparation of tert-butyl 4-[(6-chloro-3-pyridyl)methyl]-2-oxo-imidazo[4,5-b]pyridine-1 - carboxylate (Compound A14).
Figure imgf000077_0001
A flask, under argon, was charged with tert-butyl 2-(2-oxo-3H-imidazo[4,5-b]pyridin-1 -yl)acetate (commercially available, 8200 mg, 34.86 mmol), potassium carbonate (2 equiv., 69.72 mmol) and 2- chloro-5-(chloromethyl)pyridine (1 .5 equiv., 52.287 mmol) in N,N-dimethylformamide (1 equiv., 34.86 mmol). The mixture was stirred at room temperature overnight. The mixture was then filtered on Celite and the solid was washed with ethyl acetate. The combined organic phases were concentrated under reduced pressure to afford a brown oil. The brown oily residue was loaded on Isolute and dried under reduced pressure, then purified by chromatography to afford the tittle compound (2 g, 4.989 mmol, 90 mass%, 14.31 % Yield) and it undesired regioisomeric as by-product.
LC-MS (method A): Rt = 1 .0 min, [M+H]+ = 362.
Example P3: Preparation of compounds A15 to A40
To a solution of 4-[(6-chloro-3-pyridyl)methyl]-1 H-imidazo[4,5-b]pyridin-2-one (example 1 (Step F), 0.03 mmol) in N,N-dimethylformamide (0.8 mL) was added potassium carbonate K2CO3 (3 eq.), and the appropriate alkyl iodine or bromide (1 .5 eq.). The mixture was stirred to room temperature overnight. After filtration, the desired compounds were isolated by HPLC and identified by LC-MS (method B).
Example P4: Preparation of 4-[(6-chloro-3-pyridyl)methyl]-1 -(2-cyclopropyl-2-oxo-ethyl)imidazo[4,5- b]pyridin-2-one (compound A9).
Figure imgf000078_0001
A MW vial, under argon, was charged with 4-[(6-chloro-3-pyridyl)methyl]-1 H-imidazo[4,5- b]pyridin-2-one (0.3 g, 1 .1508 mmol), 1 -methyl-2-pyrrolidinone (1 .90 ml_), cesium carbonate (2.03 g, 6.2145 mmol) and 2-bromo-1 -cyclopropyl-ethanone (0.35545 g, 2.0715 mmol). The reaction mixture was submitted to microwave radiation at 100°C for 90 minutes. A mixture of water and ethyl acetate was added to the reaction and the phases were separated. The aqueous phase was extracted with dichloromethane (2X) and the combined organic phases washed with a saturated solution of sodium hydrogen carbonate. The organic phase was dried with sodium sulfate, filtered and evaporated. The crude was purified by chromatography on silica gel to afford the desired product (120 mg, 30%).
LC-MS (method A): Rt = 0.59 min, [M+H]+= 343.
Example P5: Preparation of 4-[(6-chloro-3-pyridyl)methyl]-1 -ethyl-imidazo[4,5-b]pyridin-2-one (compound A42). A possible alternative to direct alkylation, as described on example 1 (step G) is the following: To a solution of 1 -ethylimidazo[4,5-b]pyridin-2-ol (commercially available, 0.13 g) in N,N- dimethylformamide (1 .62 ml) was added potassium carbonate (0.33g, 14.6mmol, 3 equiv.) followed by 5-(chloromethyl)-2-chloropyridine (commercially available, 1 .0484 mmol, 1 .3 equiv.). The mixture was stirred at room temperature overnight. The reaction mixture was diluted with acetone and the solids filtered out. The filtrate was concentrated under reduced pressure and the remaining solid was then dissolved in MeOH and purified by reverse phase chromatography to give the title compound. The fractions were combined and a saturated solution of sodium hydrogenocarbonate was added. The organic phase was extracted with dichloromethane (5X) to give, after be dried over sodium sulfate the desired compound (31 mg, 13% yield). LC-MS (method A): Rt = 0.59 min, [M+H]+ = 289. As by-product, the 2-[(6-chloro-3-pyridyl)methoxy]-1 -ethyl-imidazo[4,5-b]pyridine was isolated.
Table A: This table discloses 42 compounds of formula (I):
Figure imgf000079_0001
Figure imgf000080_0001
Figure imgf000081_0001
Figure imgf000082_0001
Figure imgf000083_0001
Figure imgf000084_0001
Figure imgf000085_0001
Figure imgf000086_0001
Figure imgf000087_0001
Figure imgf000088_0001
BIOLOGICAL EXAMPLES:
Bemisia tabaci (Cotton white fly): Feeding/contact activity.
Cotton leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10,000 ppm dimethylsulfoxide (DMSO) stock solutions. After drying, the leaf discs were infested with adult white flies. The samples were checked for mortality 6 days after infestation.
The following compounds described in Table A resulted in at least 80% mortality at an application rate of 200 ppm:
A3, A42
Euschistus herns (Neotropical brown stink bug).
Soybean leaves on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10,000 ppm DMSO stock solutions. After drying the leaves were infested with N2 nymphs. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.
The following compounds described in Table A gave an effect of at least 80% mortality in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm:
A28, A33.
Mvzus persicae (Green peach aphid):Feeding/Contact activity
Sunflower leaf discs were placed onto agar in a 24-well microtiter plate and sprayed with aqueous test solutions prepared from 10,000 ppm DMSO stock solutions. After drying, the leaf discs were infested with an aphid population of mixed ages. The samples were assessed for mortality 6 days after infestation.
The following compounds described in Table A resulted in at least 80% mortality at an application rate of 200 ppm:
A1 , A2, A4, A6, A7, A8, A10, A1 1 , A12, A13, A14, A15, A16, A27, A28, A30, A31 , A38, A40, A42.
Mvzus persicae (Green peach aphid). Systemic activity. Roots of pea seedlings infested with an aphid population of mixed ages were placed directly into aqueous test solutions prepared from 10,000 DMSO stock solutions. The samples were assessed for mortality 6 days after placing the seedling roots into test solutions.
The following compounds described in Table A resulted in at least 80% mortality at a test rate of 24 ppm:
A1 , A3, A4, A6, A7, A8, A1 1 , A12, A13.
Mvzus persicae (Green peach aphid). Intrinsic activity.
Test compounds prepared from 10,000 ppm DMSO stock solutions were applied by pipette into 24-well microtiter plates and mixed with sucrose solution. The plates were closed with a stretched Parafilm. A plastic stencil with 24 holes was placed onto the plate and infested pea seedlings were placed directly on the Parafilm. The infested plate was closed with a gel blotting paper and another plastic stencil and then turned upside down. The samples were assessed for mortality 5 days after infestation.
The following compounds described in Table A resulted in at least 80% mortality at a test rate of 12 ppm:
A1 , A2, A3, A4, A6, A7, A10, A1 1 , A12, A13, A14, A15, A16, A28, A30, A31 , A33, A40, A42.
Tetranvchus urticae (Two-spotted spider mite). Feeding/contact activity.
Bean leaf discs on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10,000 ppm DMSO stock solutions. After drying the leaf discs were infested with a mite population of mixed ages. The samples were assessed for mortality on mixed population (mobile stages) 8 days after infestation.
The following compounds resulted in at least 80% mortality at an application rate of 200 ppm:
A16, A18, A37.
Nilaoarvata lugens (Brown plant hopper - metabolic neonicotinoid-resistant)
Rice plants were treated with the diluted test solutions in a spray chamber. After drying, the plants were infested with ~20 N3 nymphs. 7 days after the treatment, samples were assessed for mortality and growth regulation.
The following compounds gave at least 80% control of the neonicotinoid-resistant strain of Nilaparvata lugens at 200 ppm. A7, A11 , A13.
Mvzus persicae (Green peach aphid - neonicotinoid-resistant), mixed population
Pea seedlings infested with a mixed-aged neonicotinoid-resistant Myzus persicae population were treated with diluted test solutions in a spray chamber and checked for mortality 5 days after treatment.
The following compounds gave at least 80% control of the neonicotinoid-resistant strain of Myzus persicae at 200 ppm.
A7, A11 , A12, A13
Mvzus persicae (Green peach aphid), mixed population, contact/feeding
Pepper plants were infested with mixed aged neonicotinoid resistant aphid population and were treated 1 day after infestation with diluted test solutions in a spray chamber. 5 days after treatment samples were assessed for mortality.
The following compounds from Table B gave at least 80% control of the Neonicotinoid resistant strain of Myzus persicae at 200 ppm.
A10, A42.
Mvzus persicae test method for resistance factor 50 (RF50).
Cabbage leaf discs were infested with approximately 20-25 insects and sprayed with the respective insecticide dilutions in a Potter tower. Insect mortality was assessed five days after treatment.
The RF(50) is calculated by the following formula: RF(50) = LC(50) of resistant strain/LC(50) of susceptible strain, wherein the LC(50) is the lethal concentration where 50% of the population is controlled.
The following compounds in Table A gave at least a RF(50) lower or equal than 20.
A6, A11 , A12, A13.

Claims

CLAIMS:
1 . A compound of Formula (I):
Figure imgf000092_0001
wherein:
W is O or S;
R1 is Ci-C6alkyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or Ci-C6haloalkyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2;
or
C2-C6alkenyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or C2-C6haloalkenyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2;
or
C2-C6alkynyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2, or C2-C6haloalkynyl optionally substituted by 1 or 2 substituents independently selected from Ui or a single substituent selected from U2
or
C3-C6cycloalkyl optionally substituted by 1 or 2 substituents independently selected from U3 or a single substituent selected from U2;
or
cyano, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl or phenylcarbonyl;
Ui is nitro, cyano, amino, hydroxyl, CO2H, C3-C6cycloalkyl, C3-C6halocycloalkyl, Ci-C4alkoxy, Ci-C4haloalkoxy, Ci-C2alkoxy-Ci-C2alkoxy, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci- C4alkoxycarbonyl, Ci-C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl, C3-C4cycloalkylcarbonyl, =N- 0(Ci-C4alkyl), =N-0(Ci-C4haloalkyl), -Si(Ci-C4alkyl)3, (Ci-C4haloalkyl)NH-, (Ci-C4haloalkyl)2N-, (C1-C4 haloalkyl)(Ci-C4alkyl)N-, (Ci-C4alkyl)NH-, (Ci-C4alkyl)2N-, (C3-C6cycloalkyl)NH-, (C3-C6cycloalkyl)(Ci- C4alkyl)N-, Ci-C4alkylcarbonylamino, Ci-C4haloalkylcarbonylamino, aminocarbonyl, N-Ci- C4alkylaminocarbonyl, (N,N-di-Ci-C4alkylamino)carbonyl, C3-C6cycloalkylaminocarbonyl, Ci- C4haloalkylaminocarbonyl, C3-C6halocycloalkylaminocarbonyl or phenylaminocarbonyl, wherein the phenyl group is optionally substitued by a single substituent selected from halogen, methyl, methoxy or trifluoromethyl;
U2 is phenyl, heteroaryl wherein the heteroaryl moiety is a 5- or 6-membered monocyclic aromatic ring which comprises 1 , 2, 3, or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur, or a 5- or 6-membered saturated or partially saturated heterocyclic ring wherein the heterocyclic ring comprises 1 to 3 heteroatoms selected from nitrogen, oxygen and sulfur, and wherein each phenyl, heteroaryl or heterocyclic ring is optionally substituted by: (i) 1 , 2, 3, 4 or 5 independently selected halogen groups, or (ii) 1 or 2 groups independently selected from L4 and optionally a halogen group;
L is halogen, nitro, cyano, amino, hydroxyl, -CO2H, Ci-C4alkyl, Ci-C4haloalkyl, C3-C6cycloalkyl, C3-C6halocycloalkyl, C3-C6halocycloalkyl-Ci-C4alkyl, C3-C6cycloalkyl-Ci-C4alkyl, Ci-C4alkoxy, Ci- C4alkoxy-Ci-C4alkyl, Ci-C4haloalkoxy, Ci-C4haloalkoxy-Ci-C4alkyl, cyano-Ci-C4alkyl, cyano-Ci- C4haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C2-C6haloalkynyl, Ci-C4alkylsulfanyl, Ci- C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci-C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl and - C(0)NH2;
U4 is nitro, cyano, amino, hydroxyl, -SCN, -CO2H, Ci-C4alkyl, C3-C6cycloalkyl, C3- Cehalocycloalkyl, C3-C6cycloalkyl-Ci-C4alkyl, C3-C6halocycloalkyl-Ci-C4alkyl, Ci-C4haloalkyl, Ci- C4alkoxy, Ci-C4alkoxy-Ci-C4alkyl, Ci-C4alkoxy-Ci-C4alkoxy, cyano-Ci-C4alkyl, cyano-Ci-C4haloalkyl, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, Ci-C4haloalkoxy, Ci-C4haloalkoxy-Ci- C4alkyl, Ci-C4alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci- C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, Ci-C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci- C4haloalkylcarbonyl, Ci-C4haloalkoxycarbonyl, (Ci-C4alkyl)NH-, (Ci-C4alkyl)2N-, (C3-C6cycloalkyl)NH-, (C3-C6cycloalkyl)2N-, Ci-C4alkylcarbonylamino, C3-C6cycloalkylcarbonylamino, Ci-
C4haloalkylcarbonylamino, C3-C6halocycloalkylcarbonylamino, Ci-C4alkylaminocarbonyl, C3-C6 cycloalkylaminocarbonyl, Ci-C4haloalkylaminocarbonyl, C3-C6halocycloalkylaminocarbonyl, C3-C6 cycloalkylcarbonyl, C3-C6 halocycloalkylcarbonyl, -SFs or -C(0)NH2; m is 0, 1 or 2;
R2 is independently selected from halogen, cyano, amino, hydroxyl, Ci-C4alkyl, Ci-C4haloalkyl, Ci-C4haloalkoxy, Ci-C4alkoxy, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, C1-C4 alkylsulfanyl, Ci-C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci- C4haloalkylsulfonyl and cyclopropyl;
R3a and R3b are independently selected from hydrogen, halogen, Ci-C4alkyl, Ci-C4haloalkyl, Ci- C4alkoxy and cyano; R4 is selected from one of Y1 to Y4:
Figure imgf000094_0001
wherein n is 0, 1 or 2; and
U is independently selected from halogen, cyano, nitro, hydroxyl, amino, Ci-C4alkyl, Ci- C4haloalkyl, Ci-C4alkoxy, Ci-C4haloalkoxy, C2-C4alkenyl, C2-C4haloalkenyl, C2-C4alkynyl, C2-C4haloalkynyl, Ci-C4haloalkoxy-Ci-C4alkyl, Ci-C4alkoxy-Ci-C4alkyl, Ci-C4alkylsulfanyl, Ci- C4alkylsulfinyl, Ci-C4alkylsulfonyl, Ci-C4haloalkylsulfanyl, Ci-C4haloalkylsulfinyl, Ci-C4haloalkylsulfonyl, formyl, cyclopropyl, Ci-C4alkylcarbonyl or C3-C6cycloalkylcarbonyl; or an agrochemically acceptable salt, stereoisomer, enantiomer, tautomer or N-oxide thereof.
2. A compound according to claim 1 , wherein R1 is:
Ci-C6alkyl optionally substituted by 1 or 2 substituents selected from Ui or a single substituent selected from U2, or Ci-C4haloalkyl; or
C2-C6alkenyl optionally substituted by 1 or 2 substituents selected from Ui or a single substituent selected from U2, or C2-C6haloalkenyl, or
C2-C6alkynyl optionally substituted by 1 or 2 substituents selected from Ui or a single substituent selected from U2, or C2-C6haloalkynyl, or
C3-C6cycloalkyl optionally substituted by 1 or 2 substituents selected from U3; or
Ci-C4alkylcarbonyl or phenylcarbonyl; and
Ui is cyano, C3-C6cycloalkyl, Ci-C4alkoxy, C3-C4halocycloalkyl, Ci-C2alkoxy-Ci-C2alkoxy, Ci- C4alkylsulfanyl, Ci-C4alkylcarbonyl, C3-C4cycloalkylcarbonyl, Ci-C4alkoxycarbonyl, N-0(Ci-C4alkyl);
U2 is phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl or pyrazinyl, each optionally substituted by (i) 1 , 2 or 3 independently selected halogen groups, or (ii) a single L4 group selected from cyano and Ci-C4haloalkoxy; and
U3 is independently selected from halogen, Ci-C4alkyl or Ci-C4haloalkyl.
3. A compound according to claim 1 or claim 2, wherein R1 is selected from Ci-C6alkyl, Ci- Cehaloalkyl, cyanoCi-C4alkyl, Ci-C2alkoxy-Ci-C4alkyl, Ci-C2alkoxy-Ci-C2alkoxy-Ci-C2alkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C4alkynyl, C3-C6cycloalkyl, (C3-C6cycloalkyl)methyl, Ci- C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci-C4alkoxycarbonylCi-C3alkyl, Ci-C4alkylcarbonylCi-C2alkyl, Ci-C2alkylsulfanylCi-C4alkyl, cyclopropylC(0)methyl, (halocyclopropyl)methyl, -CH(C(0)0Ci-C4alkyl)2, (Ci-C4alkyl-0-N=)Ci-C4alkyl, (Ci-C4alkyl-0-N=)Ci-C4alkyl, phenylaminocarbonylCi-C4alkyl wherein the phenyl group is optionally substituted by 1 , 2 or 3 halogen atoms, or (phenyl)methyl, (thienyl)methyl, (pyridinyl)methyl, or (pyrazinyl)methyl, wherein each phenyl, thienyl, pyridinyl or pyrazinyl group is optionally substituted by a single group selected from chloro, fluoro, cyano, methyl, ethyl, ethoxy, difluoromethoxy or trifluoromethoxy.
4. A compound according to any one of claims 1 to 3, wherein R1 is selected from Ci-C4alkyl, Ci- C6haloalkyl, cyanoCi-C4alkyl, Ci-C2alkoxy-Ci-C2alkyl, Ci-C2alkoxy-Ci-C2alkoxy-Ci-C2alkyl, C2-C6alkenyl, C2-C4fluoroalkenyl, C2-C4alkynyl, C3-C4cycloalkyl, (C3-C4cycloalkyl)methyl, Ci- C4alkylcarbonyl, Ci-C4alkoxycarbonyl, Ci-C4alkoxycarbonylCi-C3alkyl, Ci-C4alkylcarbonylCi-C2alkyl, Ci-C2alkylsulfanylCi-C4alkyl, cyclopropyiC(0)methyl, (difluorocyclopropyl)methyl, -CH(C(0)0Ci- C4alkyl)2, (Ci-C4alkyl-0-N=)Ci-C4alkyl, (Ci-C4alkyl-0-N=)Ci-C4alkyl, phenylaminocarbonylCi-C4alkyl wherein the phenyl group is optionally substituted by 1 , 2 or 3 independently selected chloro or fluoro atoms, or (phenyl)methyl, (thien-2-yl)methyl, (pyridin-2-yl)methyl, or (pyrazinyl)methyl, wherein each phenyl, thienyl, pyridinyl or pyrazinyl group is optionally substituted by a single group selected from chloro, fluoro, cyano, methyl, ethyl, ethoxy, difluoromethoxy or trifluoromethoxy.
5. A compound according to any one of claims 1 to 4, wherein R1 is selected from -CFhCECH, -
CH2CF2H, cyclopropyl, -CF2H, -CH2CH2CN, -CH2CN, (2,2-difluorocyclopropyl)methyl, CH2C(0)cyclopropyl, -CF2CF2H, -CH2CF2H, -CH2CF3, -C(0)0tBu, -CH2CH2F, -CH2CH2CH2CF3, - CH2CH2OCH2OCH3, -CH2CH2CH2OCH2CH3, -CH(C02CH3)2, (5-cyanothien-2-yl)methyl,
Figure imgf000095_0001
trifluoromethoxyphenyl)methyl, (3-difluoromethoxyphenyl)methyl, (cyclobutyl)methyl, -CH2CH2CI, (5- fluoropyridin-2-yl)methyl, (pyrazinyl)methyl, -CH2CH2CH=CH2, -CH2CH2CH2CH=CH2, CH(CH3)C(H)=NOCH2CH3, -CH2C(CH3)=NOCH3, -CH(CH3)C(0)NH(3-CF3Ph), -CH2CH2CH2CI, - CH2CH3, or -CH2C(0)cyclopropyl.
6. A compound according to any one of claims 1 to 5, wherein m is 0 or 1 , and preferably 0.
7. A compound according to any one of claims 1 to 6, wherein R3a is hydrogen and R3b is hydrogen.
8. A compound according to any one of claims 1 to 7, wherein R4 is selected from Y2 or Y3.
9. A compound according to any one of claims 1 to 8, wherein n is 1.
10. A compound according to any one of claims 1 to 9, wherein R4 is:
1 1 . A compound according to any one of claims 1 to 9, wherein R4 is:
Figure imgf000096_0001
12. An agrochemical composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound according to any one of claims 1 to 1 1 .
13. The composition according to claim 12, further comprising at least one additional active ingredient and/or an agrochemically-acceptable diluent or carrier.
14. A method of controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) as defined in any one of claims 1 to 1 1 , or a composition comprising this compound as active ingredient, to a pest, a locus of pest (preferably a plant), to a plant susceptible to attack by a pest or to plant a propagation material thereof (such as a seed).
15. Use of a compound according to any one of claims 1 to 1 1 as an insecticide, acaricide, nematicide or molluscicide.
PCT/EP2019/084936 2018-12-14 2019-12-12 Pesticidally-active bicyclic heteroaromatic compounds WO2020120694A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18212718.3 2018-12-14
EP18212718 2018-12-14

Publications (1)

Publication Number Publication Date
WO2020120694A1 true WO2020120694A1 (en) 2020-06-18

Family

ID=64665691

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/084936 WO2020120694A1 (en) 2018-12-14 2019-12-12 Pesticidally-active bicyclic heteroaromatic compounds

Country Status (1)

Country Link
WO (1) WO2020120694A1 (en)

Citations (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003000906A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant disease resistance genes
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003034823A1 (en) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Treatment of fabric materials with an insecticide
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2005064072A2 (en) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2005113886A1 (en) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Method for the treatment of flexible substrates
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
EP1724392A2 (en) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Process for the microbicidal finishing of textile surfaces
WO2006128870A2 (en) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007090739A1 (en) 2006-02-03 2007-08-16 Basf Se Process for treating substrates
WO2007115647A1 (en) 2006-03-31 2007-10-18 Bayer Cropscience Ag Bicyclic enamino(thio)carbonyl compounds
WO2008151984A1 (en) 2007-06-12 2008-12-18 Basf Se Aqueous formulation and process for the impregnation of non-living-materials imparting a protective activity against pests
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
WO2012136751A1 (en) 2011-04-08 2012-10-11 Basf Se N-substituted hetero-bicyclic compounds and derivatives for combating animal pests
WO2012152741A1 (en) 2011-05-10 2012-11-15 Bayer Intellectual Property Gmbh Bicyclic (thio)carbonylamidines
WO2013144088A1 (en) 2012-03-29 2013-10-03 Basf Se N-substituted hetero-bicyclic compounds and derivatives for combating animal pests ii
WO2013150115A1 (en) 2012-04-05 2013-10-10 Basf Se N- substituted hetero - bicyclic compounds and derivatives for combating animal pests
WO2013149903A1 (en) 2012-04-03 2013-10-10 Basf Se N- substituted hetero - bicyclic furanone derivatives for combating animal
WO2014076272A1 (en) 2012-11-16 2014-05-22 Syngenta Participations Ag Pesticidal compounds

Patent Citations (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0353191A2 (en) 1988-07-29 1990-01-31 Ciba-Geigy Ag DNA sequences encoding polypeptides having beta-1,3-glucanase activity
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0392225A2 (en) 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1995033818A2 (en) 1994-06-08 1995-12-14 Ciba-Geigy Ag Genes for the synthesis of antipathogenic substances
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5631072A (en) 1995-03-10 1997-05-20 Avondale Incorporated Method and means for increasing efficacy and wash durability of insecticide treated fabric
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003000906A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant disease resistance genes
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003034823A1 (en) 2001-10-25 2003-05-01 Siamdutch Mosquito Netting Company Limited Treatment of fabric materials with an insecticide
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2005064072A2 (en) 2003-12-22 2005-07-14 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2005113886A1 (en) 2004-05-12 2005-12-01 Basf Aktiengesellschaft Method for the treatment of flexible substrates
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
EP1724392A2 (en) 2005-05-04 2006-11-22 Fritz Blanke Gmbh & Co. Kg Process for the microbicidal finishing of textile surfaces
WO2006128870A2 (en) 2005-06-03 2006-12-07 Basf Aktiengesellschaft Composition for the impregnation of fibers, fabrics and nettings imparting a protective activity against pests
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007090739A1 (en) 2006-02-03 2007-08-16 Basf Se Process for treating substrates
WO2007115647A1 (en) 2006-03-31 2007-10-18 Bayer Cropscience Ag Bicyclic enamino(thio)carbonyl compounds
WO2008151984A1 (en) 2007-06-12 2008-12-18 Basf Se Aqueous formulation and process for the impregnation of non-living-materials imparting a protective activity against pests
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
WO2012136751A1 (en) 2011-04-08 2012-10-11 Basf Se N-substituted hetero-bicyclic compounds and derivatives for combating animal pests
WO2012152741A1 (en) 2011-05-10 2012-11-15 Bayer Intellectual Property Gmbh Bicyclic (thio)carbonylamidines
WO2013144088A1 (en) 2012-03-29 2013-10-03 Basf Se N-substituted hetero-bicyclic compounds and derivatives for combating animal pests ii
WO2013149903A1 (en) 2012-04-03 2013-10-10 Basf Se N- substituted hetero - bicyclic furanone derivatives for combating animal
WO2013150115A1 (en) 2012-04-05 2013-10-10 Basf Se N- substituted hetero - bicyclic compounds and derivatives for combating animal pests
WO2014076272A1 (en) 2012-11-16 2014-05-22 Syngenta Participations Ag Pesticidal compounds

Non-Patent Citations (32)

* Cited by examiner, † Cited by third party
Title
"Advances in Experimental Medicine and Biology", LNSECT NICOTINIC ACETYLCHOLINE RECEPTORS, vol. 683, 2010, pages 75 - 83
"McCutcheon's Detergents and Emulsifiers Annual", 1981, MC PUBLISHING CORP.
"the Manual on Development and Use of FAO and WHO Specifications for Pesticides", 2010, SOUTHERN ILLINOIS UNIVERSITY
A. ALBINIS. PIETRA: "Heterocyclic N-oxides", 1991, CRC PRESS
A. WOOD, COMPENDIUM OF PESTICIDE COMMON NAMES, 1995
ARKIVOC, vol. 10, 2002, pages 90 - 96
AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 69, no. 6, 2016, pages 618 - 630
BASS ET AL., BMC NEUROSCIENCE, vol. 12, 2011, pages 51
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 18, no. 20, 2008, pages 5493 - 5496
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 25, no. 5, 2015, pages 1117 - 1123
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, vol. 60, no. 5, 1987, pages 1793 - 9
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 272451-65-7
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, vol. 48, no. 12, 2013, pages 1801 - 1804
EUR. J. MED. CHEM., vol. 113, 2016, pages 102
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, vol. 11, 2002, pages 1763 - 1769
GORMAN ET AL., PEST MANAGEMENT SCIENCE, 2010, pages 1186 - 1190
HARROP, THOMAS WR, PEST MANAGEMENT SCIENCE, vol. 74, no. 6, 2018, pages 1297 - 1301
HETEROCYCLES, vol. 57, no. 12, 2002, pages 2335 - 2343
J HET CHEM., vol. 47, 2010, pages 683
J MED CHEM, vol. 32, no. 7, 1989, pages 1566 - 71
J MED CHEM, vol. 51, no. 4, 2008, pages 875 - 896
J MED CHEM, vol. 55, no. 2, 2012, pages 852 - 870
J MED CHEM, vol. 58, no. 20, 2015, pages 8066 - 8096
JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 22, no. 4, 1985, pages 1061 - 4
JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 24, no. 6, 1987, pages 1709 - 16
MENDELEEV COMMUNICATIONS, vol. 26, no. 1, 2016, pages 69 - 71
NAUENDENHOLM, ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY, vol. 58, 2005, pages 200 - 215
ORGANIC LETTERS, vol. 15, no. 7, 2013, pages 1456 - 1459
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, vol. 121, 2015, pages 78 - 87
PROC. BCPC, INT. CONGR., vol. 1, 2003, pages 93
SYNLETT, vol. 23, no. 12, 2012, pages 1816 - 1820
SYNTH COMM, vol. 12, 1982, pages 213

Similar Documents

Publication Publication Date Title
EP3230284B1 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
EP3166941B1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
EP3240788B1 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
EP3268365B1 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
EP3585770B1 (en) Pesticidally active heterocyclic derivatives with sulfur containing substituents
EP3317275B1 (en) Pesticidally active tetracyclic derivatives with sulfur containing substituents
US20210403478A1 (en) Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2016107831A1 (en) Pesticidally active polycyclic derivatives with sulfur containing substituents
EP3548466B1 (en) Process for preparation of intermediate of pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2016058928A1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
US10945435B2 (en) Imidazopyrimidine derivatives with sulfur containing phenyl and pyridyl substituents
WO2016113155A1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2019086474A1 (en) Pesticidally active mesoionics heterocyclic compounds
EP3353173B1 (en) Pesticidally active polycyclic derivatives with 5-membered sulfur containing heterocyclic ring systems
WO2019076778A1 (en) Pesticidally active heterocyclic derivatives with sulfur and sulfonimidamides containing substituents
EP3649118A1 (en) Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2018215304A1 (en) Tetracyclic pyridazine sulphur containing compounds and their use as pesticides
WO2016012395A1 (en) Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2020120697A1 (en) Pesticidally-active cyanamide heterocyclic compounds
WO2020030503A1 (en) Pesticidally-active bicyclic heteroaromatic compounds
WO2020011808A1 (en) Pesticidally-active bicyclic heteroaromatic compounds
WO2020025658A1 (en) Pesticidally-active bicyclic heteroaromatic compounds
WO2020120694A1 (en) Pesticidally-active bicyclic heteroaromatic compounds
WO2020035565A1 (en) Pesticidally-active mesoionic bicyclic heteroaromatic compounds
WO2020030754A1 (en) Pesticidally-active mesoionic bicyclic heteroaromatic compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19827672

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19827672

Country of ref document: EP

Kind code of ref document: A1